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Abstract
Intensity modulated arc therapy is a novel treatment technique that has shown great poten-
tial to be superior to conventional intensity modulated radiotherapy, both in terms of treat-
ment plan quality as well as treatment delivery. Based on previous literature, a simplified
technique called two-step intensity modulated arc therapy (2-step IMAT) was implemented
into a treatment planning system. In order to automatically generate treatment plans for
this technique, a beam portal shaping method was developed to generate beam segments. A
sensitivity analysis was carried out on a geometric phantom to determine optimal parame-
ters for the 2-step IMAT implementation for that particular phantom. The segment weights
were optimized using the dose-based and dose-volume-based objective functions. The opti-
mal solution search was based on the gradient-descend algorithm. The dose-based objective
function was implemented using a so-called lambda-value-dose-based objective function de-
veloped in this work in order to increase both speed and flexibility of the optimization. The
successful implementation demonstrated the feasibility of automatic 2-step IMAT treatment
planning.
A comparison of conventional arc therapy and 2-step IMAT showed improvements in the
target dose uniformity by about 50% for both geometric phantom and clinical paraspinal
tumor case, whilst also improving the organ sparing. The comparisons between the lambda-
value-dose-based and dose-volume-based optimizations showed a speed advantage of the
former by a factor of over five in the phantom study.
The current beam portal shaping approach can be improved by optimizing the segment
width and including multiple organs-at-risk in the segment generation algorithm. Future
work will also include the implementation of a stochastic optimization to minimize the chance
of getting trapped in local minima during the segment weight optimization. In summary, the
work of this research showed that the automatic 2-step IMAT planning is a viable technique
that can result in highly conformal plans while keeping the treatment planning and delivery
simple and straightforward.
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Ionizing radiation is one of main methods currently used to treat cancer. Unlike surgery and
chemotherapy, radiation therapy is neither invasive nor painful to the patients. Nearly all
types of cancer are treated with radiotherapy as the sole or adjuvant treatment method to
eliminate cancer cells [8]. The linear accelerator (linac) is most commonly used to deliver
photon or electron beams to the patient [9, 10, 11]. In this work only photon therapy will
be considered. During the radiation treatment, the patient lies on a treatment table and the
linac irradiates the patient from different angles. To reduce treatment errors due to patient
movement, the patient may be immobilized by e.g. a vacuum bag, a frame or masks during
the treatment. Using highly attenuating material, the radiation beams are shaped individ-
ually to the shape of the target volume in the beams-eye-view (BEV). Thus, irradiation to
radiosensitive organs is blocked to minimize the complications, thus prolonging the lifespan
of the patient. Common radiation treatment techniques include conformal radiotherapy,
intensity modulated radiotherapy and intensity modulated arc therapy. Each technique will
be introduced in the following sections.
1.1 Conformal Radiotherapy
The aim of the conformal radiotherapy (CRT) is to irradiate the tumor uniformly while
at the same time keeping the normal tissue exposure to a minimum level. Originally, the
radiation beams were shaped using physical cerrobend blocks [2, 11]. The shape of the
beams, and hence the cerrobend blocks are patient specific. As the shape of the target
in the BEV changes while the linac gantry rotates to different angles, it is impractical to
manufacture different block shapes for each beam and each patient. In modern treatments
the cerrobend blocks are replaced by the multi-leaf collimator (MLC) mounted onto the linac.
The MLC consists of two banks of attenuating leaves, typically made of tungsten, that slide
parallel to each other. By sliding each individual leaf towards or away from its opposing
leaf, the device is able to form irregular shapes as shown in Figure 1.1. The advantage
of using an MLC over conventional blocks is that the MLC has the ability to change the
beam shape to most irregular shapes freely during the treatment. Therefore, the process
of manufacturing individual blocks is eliminated. This makes it a more practical approach
when the beams are delivered from different angles and the target is irregularly shaped. An
initial survey conducted by Klein et al showed that more than one third of facilities that
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used MLC, suggested that they could treat more patients with MLC machines and more
than 90 percent facilities could reduce the workload of therapist [12].
Figure 1.1: MLC conforms around the target in the BEV to form the beam portal (or
aperture).
The conformal radiation treatment using MLC was introduced by Takahashi in 1965
[13]. The beams are shaped around the tumor depending on the geometry of the organs
and the beam angle. The radiation treatment using the 3D organ information to shape
the beams is called the 3-dimensional conformal radiotherapy (3D CRT). The availability
of three-dimensional (3D) volumetric information of the organs from the modern imaging
modalities increases the accuracy of the MLC setup.
Typically a certain number of beam directions are used for treatment. The beam ar-
rangements are based on the experience of the clinician. It may be optimized manually or
automatically [6]. In this so-called “forward planning” process, the beam portals are firstly
generated. During this process, the planner then changes the relative beam weight of each
beams by the trial-and-error method in order to achieve a conformed treatment plan. 3D
CRT is able to reduce the radiation damage to the healthy tissues better than the conven-
tional techniques without 3D volume information. However, with a uniform beam intensity
profile of each beam it is sometimes difficult to deliver a conformal dose distribution around
the target tumor whilst at the same time spare the normal tissues. In particular, if the target
volume is concavely shaped and a radiosensitive organ is located in the concave region of
the tumor, healthy tissue sparing has to be compromised in order to achieve a reasonable
tumor dose coverage. This in turn limits the dose that can be safely delivered to the tumor.
In this situation, uniform beams are not sufficient and beam intensity modulation may be
required.
1.2 Intensity Modulated Radiotherapy
Intensity modulated radiotherapy (IMRT) is an advanced form of 3D CRT. For IMRT,
treatment plan is generated using “inverse planning” method. Rather than manually trying
different beam weights to find a desired dose distribution, the plan objectives are initially
defined and an ideal fluence distribution of the beam intensity is obtained.
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The most significant feature of IMRT is that the beam intensity at each angle is mod-
ulated to achieve a conformal dose distribution in the target volume. Figure 1.2 shows an
example of the treatment of prostate cancer using IMRT from three angular directions. Note
that the three beam directions are only used to illustrate the principle of IMRT, different
angle combinations would be used clinically. The target in this case is a tumor with two
concave regions, each of which is adjoined by a radiosensitive organ, the bladder and the
rectum. In order to maximize the sparing of the healthy tissues, the intensity profiles of the
three beams are modulated as shown in Figure 1.2. Since there is no critical tissue on its
path, the beam irradiating from the lateral side of the patient has a high peak profile so that
the prostate receives maximum radiation from this angle. In contrast, the anterior beam
has low intensity at the center of the profile in order to reduce the radiation delivered to the
rectum. In summary, the intensity profiles from all gantry angles are modulated differently
so that the target receives a conformal dose whilst the healthy tissues are spared.
Figure 1.2: Illustration of 1D modulated beam intensity profiles in an IMRT treatment. The
intensity modulated radiation beams are delivered to the prostate from three possible gantry
angles in this cross section image [1].
The MLC plays an important role in generating non-uniform intensity profiles during
IMRT treatment. In Figure 1.2 ideal 1D intensity profiles are shown for one cross section
of the patient. In the BEV, the intensity profile is a 2D distribution as shown on the right
side of Figure 1.3. The intensity profile in Figure 1.3 can be delivered through four different
beam segments. Each beam segment is shaped using the MLC in order to deliver the contour
of each intensity level. To approximate the continuous 2D intensity contour map, a discrete
representation is used (see Figure 1.4). The matrix is a discrete representation and each
unit area (or element of the matrix) is called “bixel”. The intensity profile of the beam is
approximated by assigning each bixel with an intensity value, each represents the height of
the intensity in the perpendicular direction from the 2D plane. The matrix is then used as
a guide for the MLC to shape beam segments in order to produce a desired 2D intensity
profile.
The non-uniform intensity profile characteristic of IMRT is able to produce a more con-
formal dose distribution while sparing healthy tissues. This achievement comes with the
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Figure 1.3: Illustration of continuous 2D intensity map. The intensity contour map in the
BEV with four levels can be generated with four beam fields [2].
Figure 1.4: Discrete 2D intensity matrix. There are three intensity levels in this nine element
matrix.
compromise of complicating the planning process. In order to achieve a given intensity
profile, there are many possible solutions to setup the beam fields for each intensity level.
One simple illustration is shown in Figure 1.5 [3]. In the same paper, Yu derived that for
a single-peak profile, there are (N !)2 possible MLC beam field setups in a one-dimensional
case with N intensity levels. The figure shows three of thirty-six possible beam field setups
in order to achieve the same intensity profile for one pair of the MLC leaves. The possible
solutions will increase when considering a two-dimensional intensity map (all pairs of the
MLC leaves) and the problem will become more complicated as certain physical restrictions
of the MLC setup need to be taken into account, such as the maximum overtravel distance
of the MLC [2]. In addition, the complexity of the intensity maps complicates the treatment
plan physically. The more intensity levels a beam profile has the more beam segments are
required to generate such a profile, thus the larger the beam penumbra effects on the quality
of the treatment plan [11, 14].
Comparing conventional 3D CRT and IMRT, the former is simpler in planning and
delivery, thus the time to plan and deliver is shorter. On the other hand, IMRT is able
to create more sophisticated quality plans, especially in complicated cases that involve a
concave-shaped target. However, the compromise of a more conformal IMRT plan is the
longer time for planning and delivery and so is the higher equipment requirements. In order
to reduce the treatment time and improve the efficiency of the treatment delivery, a rotational
irradiation technique was developed and has recently become available commercially. Both
Varian (Palo Alto, USA) and Elekta (Stockholm, Sweden), have implemented the so-called
“intensity modulated arc therapy” and branded it as RapidArcTM and VMAT (Volumetric
Modulated Arc Therapy), respectively.
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Figure 1.5: Three possible beam fields combination consisting of three segments. Each
combination generates the same 1D intensity profile as shown in (a) [3].
1.3 Intensity Modulated Arc Therapy
Intensity modulated arc therapy (IMAT) was first introduced by Yu in 1995 [3]. IMAT is a
rotational treatment, which irradiates the target while the gantry rotates around the patient.
The beam segments and even the dose rate may be changed continuously [15, 16, 17]. Both
the shape and the relative weight of each segment are obtained from inverse planning. Unlike
conventional 3D CRT and IMRT with limited number of fixed gantry angles, radiation is
continuously delivered during gantry rotation in the IMAT treatment [15, 16]. This provides
a more completed directional coverage of the target.
Although the overall benefit of IMAT over the former two techniques is still subject of
debate [7, 15, 18, 16, 19, 20], there are two definite advantages of the IMAT technique. The
continuous irradiation during the gantry rotation is more efficient than the IMRT techniques
in terms of radiation delivery. Recent studies have showed the delivery time advantage of
IMAT over IMRT for different treatment sites [21, 22, 23, 24]. For example, a study done
by Cozzi et al compared IMRT and RapidArcTM for treating cervical cancer. Their work
showed that IMRT may take as long as 15 minutes to deliver one fraction of radiation
treatment, while IMAT only required one to two minutes to do so [21]. Furthermore, the
increased number of irradiating angles reduces the intensity modulation required for each
beam. Overall, the dose deposited to the surrounding normal tissues decreases [21].
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1.4 2-Step Intensity Modulated Arc Therapy
In this work a treatment technique called 2-step intensity modulated arc therapy (2-step
IMAT) is implemented into a computerized treatment planning system. The 2-step IMAT
technique was first introduced by Bratengeier in 2001 [4]. The radiation beams are delivered
to the target tumor continuously during two gantry rotations [4, 25, 26, 27, 28, 29]. Radiation
is delivered to the planning target volume (PTV) through two beam segments, called the
1st order and 2nd order segments. They were defined as the 1st and 2nd order segments in
Bratengeier’s paper [4]. The beam shaping and the resulting intensity profile are illustrated
in Figure 1.6a and b, respectively. Each segment is delivered during one continuous gantry
rotation. All beam segments avoid the organs-at-risk (OAR), so that it can be spared.
Although the beam intensity profile of each segment is uniform, the sum of the two segments
from each angle produces a non-uniform intensity profile shown in Figure 1.6b. The resulting
beam intensities are therefore modulated.
Figure 1.6: Illustration of (a) 2-step IMAT beam segmentation and (b) intensity profile.
Reproduced based on Bratengeier’s literatures [4].
Irradiating the PTV region near to the OAR during the second gantry rotation may
seem contradictive to the aim of the radiotherapy, which is to maximally spare the OAR.
However, this can be explained by the work done by Brahme et al in the early 1980s [5, 30].
In their work, a cylindrical phantom with a ring shaped PTV surrounding the organ at
risk at the center of the cylinder was studied (see Figure 1.7). The beam was blocked from
the edge of the OAR to spare the critical structure completely (the scattering effects were
ignored in their study for simplicity), so that only the PTV was irradiated. The phantom
was rotated 360◦ while the photon beams switched on to simulate the rotational treatment.
The significance of their study was that they found that in order to achieve a conformal
dose distribution inside the PTV, a physical non-linear filter was required to be placed in
front of the beams, see Figure 1.7. The function of the filter was to create a non-uniform
beam intensity profile, thus to improve the dose uniformity inside the PTV. The comparison
between dose distributions of un-modulated beam and the modulated beam is shown in
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Figure 1.8. Curve 1 represents the beam intensity profile and curve 2 represents the radius
dose distribution inside the PTV. The uniform beam shown in the left graph, corresponding
to a conformal arc without intensity modulation, resulted in a dose distribution with a broad
“shoulder” [30]. The intensity modulated beam shown in the right graph is able to increase
the steepness of the dose curve so that the dose distribution in the PTV becomes more
uniform.
Figure 1.7: Photon beam is modulated by a filter before irradiating the cylindrical target
[5].
Figure 1.8: Intensity profile and dose distribution comparison of without (left) and with
(right) filter modulation [5]. (Curve 1 is the beam intensity profile, curve 2 is the dose
distribution and curve 3 is the fractional dose contribution resulted by the filter).
The physical filter is able to generate continuous beam intensity fluence. Different pa-
tients have different organ geometries projecting differently from different gantry angles.
This requires individually shaped beam modulation for each patient and each gantry angle.
7
To approximate the intensity profile, one can create beam segments to generate a discrete
intensity profile as shown in Figure 1.6, which is in fact the principle of the 2-step IMAT
introduced by Bratengeier [4]. Because of the two distinct characteristics of the 2-step IMAT
technique, i.e. continuous rotational treatment and simplified beam intensity modulation, it
is hypothesized that the quality of the treatment plan can remain at a reasonable level while
the complexity of the treatment planning and delivering process can be reduced.
1.5 Outline of Thesis
In this work, 2-step IMAT was implemented for the first time into a treatment planning
system and an automatic process was developed to automatically generate 2-step IMAT
treatment plans in the planning system. The properties of 2-step IMAT was then investigated
through simulation.
The work of this thesis includes the development of the computer software module and the
subsequent analysis of the 2-step IMAT technique implementation. Two software programs
were developed, an automatic treatment plan generation program developed in the Prism
Treatment Planning System and the treatment plan optimization scripts programmed in
MATLAB. The work on the development of each program will be discussed in two separate
chapters, Chapter 2 and 3, respectively. At the end of Chapter 3, the interaction between
the two computer programs is described. The analysis of the 2-step IMAT implementation
on the geometric phantom is discussed in Chapter 4 and 5. Finally, Chapter 6 shows the




In this chapter, the treatment planning system used in this work is introduced. This is
followed by a detailed discussion of the software module development that was implemented
for automatic 2-step IMAT treatment plan generation.
2.1 PRISM
The treatment planning system (TPS) used in this work is the Prism TPS, which was
developed at the University of Washington. The system was programmed in the Common
Lisp language. The Prism source code is freely available for non-commercial use. To run
Prism, the user requires a Linux environment and an Allegro Common Lisp [31]. The system-
user interaction can be conducted under the X Window environment. The user can remotely
connect to the Prism machine and operate the system through the X server. Once the Prism
TPS is running, the user selects a patient case to be planned from the database and then
creates a treatment plan manually. Within a plan, the properties of each beam may be
specified from various control panels.
In order to modify and add new features to the Prism system, one needs to program in
the Common Lisp language. The Common Lisp language is standardized from the previous
dialects in the Lisp family of languages. A particular feature is the Common Lisp Object
System (CLOS) that can build high level abstract object-oriented program. Such ability
overcomes other popular language, such as C++, in the object-oriented programming sense.
The Prism TPS was chosen in this work because of the following reasons [32]:
1. Unlike other commercial software, the Prism TPS is free of charge for research purpose.
2. The existing graphical interface program, SLIK (simple Lisp interface kit) provides
many common graphical interface components, such as scroll list, text box and press
button. Therefore, it reduces the workload of this work in developing graphical user
interfaces.
3. Unlike other languages, the Common Lisp language has the ability to run uncompiled
and compiled functions alongside. This feature provides the convenience in the program
development process. The programmer is able to program and test new functions while
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the compiled standard Prism TPS is running, this freedom of interacting with the
system increases the efficiency of the program development.
4. The Prism TPS is an object-oriented program, which allows developers to add new
functionalities into the software. This ability of expansion of functions enables the
system to evolve over time.
The abstract object-oriented design of the Prism TPS makes it easier to understand the
existing codes and to add new software modules to the TPS. Many frequently used items in
the radiotherapy treatment planning process, such as patient, plan and beam are defined
as objects in the Prism TPS. There are attributes corresponding to each type of objects.
For example, gantry-angle, monitor-units and collimator-angle are three of the many
attributes of the beam object. To generate a beam irradiating the patient with 90 monitor
units (MU) at a 20◦ gantry angle, the following Prism command is used:
(let ((new-plan (make-plan ‘‘My Plan’’)))
(setf new-beam (make-beam ‘‘My Beam’’ :gantry-angle 20.0
:monitor-units 90.0))
(coll:insert-element new-beam (beams new-plan)))
The function of the above command is to insert a beam called “My Beam” into a plan
named “My Plan”. The attributes of the beam object, gantry-angle and monitor-units
are assigned with values during the creation of the beam object. It can be noticed from the
last line of the commands that the beam object is actually an attribute of the plan object.
Real world entities are represented by CLOS objects that interact with each other as shown
in the above example. With such abstract object-oriented programming ability, the Prism
TPS becomes a highly expandable system to implement new treatment techniques.
In the treatment planning and dose calculation sense, the Prism TPS is chosen for the
following reasons [33, 34, 35]. The system is able to read and display clinical CT images in
DICOM (digital imaging and communications in medicine) format. The treatment planner
can use various control panels (see Figure 2.1), which were developed using SLIK, to design
3D CRT treatment plans and brachytherapy plans. The contours of organs are created by
specifying points along the boundary of the organ. The dose calculation algorithm of the
Prism TPS uses the pencil-beam, non-convolution algorithm [36]. Such algorithm may not
be as dosimetrically sophisticated as the convolution/superposition algorithm or the Monte
Carlo algorithm, but it is fast in calculating the dose. Therefore, it is a good choice for
implementing and testing new treatment techniques.
2.2 2-Step IMAT Implementation
The Prism TPS has the ability to generate treatment plans but in a manual manner, thus the
user is required to set the treatment plan parameters, such as gantry angle, couch position
and beam portal for each beam in different panels. Due to the massive beam number in
the 2-step IMAT treatment plan, it is extremely time consuming and heavily labor intense
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Figure 2.1: A desktop screenshot with some of the Prism TPS panels.
to manually create such a treatment plan, especially for the beam portal shaping process.
Therefore, a user-friendly graphical user interface that can automatically generate the 2-step
IMAT treatment plans is essentially required.
2.2.1 Graphical User Interface
Programming in the Common Lisp language, a graphical user interface (GUI) was developed
for 2-step IMAT treatment planning (see Figure 2.2). The treatment planning GUI is dis-
cussed briefly in the following paragraphs in order to provide the necessary context in this
thesis.
For a true full arc therapy treatment plan, there is an infinite number of beam angles
because of the continuous irradiation during the gantry rotation. In the computer treatment
planning simulation, a discrete number of beam angles is used to approximate the effect of
the continuous arc therapy to conserve planning time. Therefore the treatment planner needs
to specify the starting angle of the gantry rotational arc and the angle separation between
adjacent beam angles. This operation can be completed by typing the inputs into the two
textboxes at the top of the treatment planning GUI shown in Figure 2.2. The treatment
planner has the freedom to specify the 2-step IMAT treatment plan parameters, such as the
width of the second beam segments, in the GUI shown in Figure 2.2. The scroll lists allow
planner to select the organs upon which the beam portals are designed (see Section 2.2.2 for
detail).
The treatment planning GUI has three choices for different radiotherapy treatment plans,
i.e. conventional arc therapy plan and two types of 2-step IMAT plans. The differences of
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Figure 2.2: The GUI developed in this work to automatically generate 2-step IMAT treat-
ment plan.
the two types of 2-step IMAT plans will be discussed in detail in Section 2.2.3.
By clicking on the button of a particular treatment, the treatment planning program will
automatically generate the corresponding beam segments from each angle and then insert a
new treatment plan into the Prism TPS. The entire operation is straightforward and easy to
follow, the input into the GUI panel is sufficient for the program to generate a 2-step IMAT
treatment plan.
2.2.2 Beam Portal Generation
Because of its close relation to the analysis work of this thesis (Chapter 4), the technique
used for shaping the beam portals will be discussed in detail in this section.
The 3D volume information of the region of interest (ROI) can be generated by contouring
structures on each CT slice. The contours of the ROIs are then used as a guide for the
generation of the beam portals [2, 10].
Beam Shaping based on Ray-Tracing
The beam portal can be shaped using the ray-tracing technique. The path of all the rays
are from the radiation source through the patient and then towards a distant imaginary 2D
plane behind the patient. Figure 2.3 schematically illustrates the ray-tracing technique used
in the beam portal shaping process [6]. Every ray from the source goes through a particular
point on the 2D plane, on which all the ROI contours are also projected as shown on the
leftside of Figure 2.3.
The overlap of the ROI projections and the point matrix on the 2D plane provides
information on which points are within certain ROI. And then all the points within the
PTV, for instance, will form the approximate shape of the PTV on the 2D plane. Among
the points within the ROI, only those close to the edge of the ROI are used to set the beam
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portal as the MLC leaves are pushed to these boundary points.
Figure 2.3: An illustration of the ray-tracing technique for beam portal generation. The
leftside diagram shows the organ layout in the beams-eye-view with uniform points matrix
(black points are within the PTV and white points are outside the PTV). The rightside
diagram shows the transversal view of the setup. It can be seen from the left diagram that
the spatial resolution of the point matrix influences the determination of the MLC setup [6].
The point separation size (or the spatial resolution) of the point matrix on the 2D plane
influences the outcome of the MLC positioning in both accuracy and time consumption.
On the one hand, a large separation size reduces the number of rays in consideration thus
requires less time to calculate and setup the MLC leaves. On the other hand, the higher
spatial resolution of the point matrix indeed improves the accuracy of the MLC setup, but
the time of calculation is prolonged and more computer memory is required. Additionally,
in a situation when the relatively small and big organs exist at the same time, optical
nerve versus brain stem for example, the small separation size or a various spatial resolution
depending on the size of the smaller organ is essential in order to detect the smaller organ.
Therefore the treatment planning process will be complicated accordingly.
In this work, more efficient and less organ size dependent ray-tracing technique was
developed to create the beam portal. Such a technique was implemented for one PTV and
one OAR only. Future work will allow to include multiple PTV and OARs.
Beam Shaping for 2-Step IMAT
The CT images are usually in the transversal plane and all image slices represent the 3D
volume of the patient. Therefore, the contour lines of the ROI are drawn on these transversal
images. On each slice there is a set of 2D structures for each ROI. At any particular gantry
angle, one can set the MLC leaves based on the geometry of these contours in the BEV.
In the Prism TPS, the coordinates of the BEV and the gantry are defined differently, so a
coordinate transformation has to be conducted during the portal shaping (the details of the
coordinate transformation can be found in [37, 35]).
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Assume that there is no MLC rotation and the MLC leaves slide in parallel to the
transversal image slices. Take the cylindrical phantom in Figure 2.4 for example. Because
of its cylindrical geometry, from each gantry angle the sum of all the contour slices of the
PTV and the OAR appear as a rectangular shape in the BEV. If one wants to shape a beam
portal such that it only irradiate the left part of the PTV. In the conventional technique,
all the ROIs need to be projected onto a distant 2D bixel map and then the beam portal
is shaped by sliding one side of MLC leaves to the points close to the left edge of the PTV
and the other side to the points close to the left boundary between the PTV and the OAR.
The error of the MLC setup varies depending on the size of each bixel. The modified beam
portal shaping technique for 2-step IMAT is able to minimize the MLC setup error due to
the spatial resolution of the point matrix. The first step is to search the boundary points
on the PTV and the OAR contours on each slice, and then the MLC leaves are slided to
these points to shape the beam portal (see Figure 2.4b). During the beam portal shaping,
the PTV points are actually shifted to left by certain distance, so that this PTV margin is
able to reduce the effect of the beam penumbra.
In the example shown in Figure 2.4, these boundary points will be the minimum contour
points of the PTV and the OAR in that particular angle. As the gantry rotates around
the phantom, the geometrical relation between the PTV and the OAR contours boundary
points in the BEV changes accordingly, and so does the beam portal shape. For example, if
the gantry rotates clockwise in Figure 2.4, the width of the beam portal will decrease. At
the time when the minimum OAR points are equal or less than the PTV minimum points
in the MLC coordinate, the MLC leaves are set to close in order to maximumly spare the
OAR. The example shown in Figure 2.4 will not have the MLC leaves closed at any angle,
since the OAR is completely within the PTV.
Comparing to the previous technique, the simplified technique is not influenced by the
point separation size and it only requires the contour information and coordinate transfor-
mation calculation. Therefore, it is more efficient and accurate. Furthermore, as long as
there is a contour drawn on each slice, the corresponding organ can be detected using this
technique. As a result, the modified beam portal shaping technique is able to eliminate
the problem encountered by the conventional technique in situation when the size difference
between the PTV and the OAR is significantly large.
The beam portals for all the gantry angles are shaped using this simplified technique. In
a 2-step IMAT treatment planning, the user can also use the GUI to specify the width of
the second order beam segment portal and these beam portals will be shaped in a similar
manner. Furthermore, certain size of margin was applied to the PTV side of the MLC leaves
counter the penumbra effect.
2.2.3 PTV Coverage
At any gantry angle, the PTV has the following BEV geometry in situation when the PTV
is larger than the OAR. First, the PTV is divided into two regions that do not overlap with
the OAR in the BEV, such as for the gantry angle shown in Figure 2.5. Another situation
occurs at certain angles where part of the PTV overlaps with the OAR and the other side
does not. This is the case when the gantry irradiates the PTV horizontally in Figure 2.5.
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Figure 2.4: Illustration of the 2-step IMAT beam portal setup. The left diagram shows a
transversal plane of the PTV, the OAR and the radiation beam. The right diagram shows the
beams-eye-view. The PTV and OAR points are the boundary points on the corresponding
contours, and the MLC leaves are pushed to these points to form a beam portal which
provides the beam shown on left.
Figure 2.5: Illustration of the ideal beam intensity profiles. The geometry shown here
provides two possible beam portals at this gantry angle, each portal is on one side of the
OAR. Ideally, one wants to deliver both portals at the same time to reach the maximum
efficiency and dose coverage [7].
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In order to maximumly spare the OAR, one can irradiate only the PTV region that is not
overlapped with the OAR. Ideally, the MLC leaves need to be shaped so that the OAR is
always shadowed by the MLC at all gantry angles, such as the intensity profile shown in
Figure 2.5. Then the ideal intensity profiles becomes as shown in Figure 2.6, in which the
OAR is always spared while the efficiency of the PTV irradiation remains at a maximum
[7]. However, such attempt is limited by the physical facts of the MLC, even by rotating the
MLC leaves 90◦ the limitation still exists. Firstly, the width of the MLC leaves is constant
so the leaves may not exactly shadow a random size OAR. Secondly, if the leaves are able
to block the OAR (say, the width of a leaf is 0.5mm and the width of the OAR is 2cm in
the BEV), the straight leaves can only shape the organ with a non-curvature side along the
MLC sliding direction. As a result, only one side of the PTV in Figure 2.6 can be irradiated
without rotating the MLC leaves during one gantry rotation and the two “banks” of the
beam intensity becomes single “bank” as shown in Figure 2.7.
One can perform a second gantry rotation which produces the other side of the “intensity
bank” to the PTV, so that the ideal intensity profile can be achieved. In Chapter 4.6 a
comparison between one-side irradiation (one arc) and two-sides irradiation (two arcs) will
be discussed in detail to explore this unknown.
2.3 Concluding Remarks
In this chapter the treatment planning system has been introduced, the abstract object-
oriented design of the software provides the convenience to implement and study the 2-step
IMAT radiotherapy technique. Furthermore, a simplified beam portal generation method
has been developed in order to efficiently create the beam portal with less setup errors. In
the next chapter, the treatment plan optimization concept and work will be discussed.
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Figure 2.6: Graph of the beam intensity versus gantry angle and MLC position in an ideal
arc therapy. The purpose of the middle sine wave shape intensity valley is in order to spare
the OAR [7].
Figure 2.7: Graph of the beam intensity versus gantry angle and MLC position in a sinlge-arc
therapy. Since only one side of the intensity “bank” can be delivered during one rotation,
the other side of the intensity “bank” becomes null as the MLC leaves shadows from the




The implementation of 2-step IMAT was divided into two parts, the beam segment generation
(Chapter 2) and the segment weight optimization. In the standard Prism TPS, the default
setting is that plans are generated by selecting a certain number of beam directions with
each beam having the same beam weight. As the MU of each beam is non-optimized to start
with, the resulting dose distribution may not be optimal. As a result, the segment weight
optimization is required to maximize the dose conformity inside the PTV and minimize
the OAR irradiation. Beam or segment weight optimization is typically done manually
for standard 3D CRT. In this chapter, the work on the development of the beam weight
optimization approach as well as some improvements are discussed.
3.1 Introduction
Optimization plays an important role in treatment planning and there are two kinds of treat-
ment plan optimization process, namely forward and inverse planning as already mentioned
in Chapter 1. In the former optimization process, the treatment planner tries different pa-
rameter setups, such as various beam angles and corresponding beam weights. The dose
distribution is calculated and manually adjusted if required. On the other hand, for inverse
planning the planner specifies the desired dose objectives for a fixed number of beam direc-
tions and then lets the optimization find the ideal intensity maps that delivers the optimum
result during the inverse planning processes. Comparing the two process, the forward opti-
mization requires the treatment planner to have sufficient amount of clinical experiences in
order to create a plan with reasonable quality with small number of tries. Forward planning
becomes increasingly time consuming as the complexity of the treatment increases. The com-
bination of all the possible gantry angles and beam weights, for example, make it impractical
to find the globally optimal plan in a manual trial-and-error process. In contrast, during
the inverse planning process the computer searches for the best parameter setup based on
the specified plan objectives. Therefore, the planning process becomes automatized and the
optimization of complex treatments becomes possible.
Ideally, one needs to optimize all possible parameters in order to achieve an optimal plan.
Instead, the planner can optimize a single parameter while fixing the other parameters so that
the complexity of the optimization process can be reduced. In this work, the beam energy
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and the beam portal shape were selected prior to the optimization as described in Chapter 2.
Only the beam weights, by means of the MUs, were varied during the optimization process
in order to find the best solution so that a predefined set of plan objectives, such as a desired
dose distribution and tolerance doses to the critical organs, can be satisfied.
There are two main types of objective function used in radiotherapy treatment plan
optimization, physical-based and biological-based [38, 39, 40, 41, 42, 43]. The biological-
based optimization uses the knowledge of the radiobiological effects on the tissues to find an
optimal plan, so that the tumor control probability is maximized while keeping the normal
tissue complication probability at a minimum [42, 43]. More commonly used is the physical-
based optimization, which optimizes dose based objectives. In this work, the latter objective
function was employed.
Appropriate definition of dose objectives is essential for the physical-based optimization.
Before describing the optimization in the following sections, the method to define and repre-
sent the organs-of-interest, as well as the dose calculation for that volume will be discussed.
3.2 Volume Definition
As the shape of the typical organ is irregular, the general geometry equation does not usually
apply to such shape of organ to calculate the volume. In the treatment planning process,
the point sampling is often used for approximating the volume of irregular organs. There are
two types of sampling method, uniform and random sampling. The uniform grid sampling
method generates equally spaced points within the organ, each point represents the center
of a cubic volume. By multiplying the cubic volume with the number of points lying inside
the organ, the total volume of the organ can be calculated [44, 45]. Conversely, the random
sampling method uses a normal probability to generate the points and then calculates the
volume in a similar manner [46, 47].
In this work, the uniform sampling method was used for its simplicity to implement.
During the sampling process, a cubic box was created to surround the entire volume of
interest (VOI). Then points were uniformly generated in the box and each point can represent
the center of a small cubic volume. As a result, the box was actually divided into many
smaller cubic volumes called voxels, each of which represents a part of the cubic box and
the sum of all voxels equals to the volume of the box. The center of each voxel (or each
point created) is used to represent the position of that voxel. Whether a particular voxel is
within the VOI is determined by whether the center of that voxel (or the point created) is
within the VOI, as shown in Figure 3.1. The volume of the VOI can be determined by the
total volume of voxels lying inside the VOI. The dose delivered to the VOI can be calculated
using this voxel information.
One drawback of the uniform sampling is its inefficiency of using a cubic box to generate
voxels, especially when the VOI is irregularly shaped. This method indeed wastes equipment
resources by generating voxels outside the VOI, but it is easy to implement and guarantees
the full coverage of the VOI.
Since the center of the voxels is used to define the location of the voxel, the size of the
voxel is crucial to determine the volume of the VOI. As the voxel size increase, the uncertainty
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Figure 3.1: A discrete 3D matrix is created surrounding the organ, the voxels whose center
points are located within the organ contour are used to represent the partial volume of the
organ and the dose deposited into those voxels are the dose received by that organ.
of the VOI determination increases accordingly. Ideally, one wants to use infinitely small
size voxels to determine the VOI, but it is time and equipment resource consuming and the
benefits of using infinitely small voxels is unknown. This will be investigated in Section 4.2.
3.3 Dose Calculation
Depending on its direction and weight, each beam has a certain contribution on each voxel
to that organ. One can construct a matrix consisting of all the contributions to the organ
voxels from each of the beams. The normalized matrix can be used as a constant multiplied
by the beam weights to calculate the dose to each voxel. The calculation can be expressed
by the following equation:
M · x = d (3.1)
The vector x is a collection of the beam weights. Each element in the row of the matrix M
shows the contribution of different beams to a single point and each element in the column
of the matrix M shows the contribution of a single beam to different points. For example,
if a plan consists of three beams ((x1, . . . , x3)) and there are four points (d1, . . . , d4) are
sampled inside the organ, the calculation of the dose deposited to the four points is given















To this point, one can consider the dose calculation as a matrix multiplication in a multi-
dimensional space, where the number of the variable dimension is defined by the number
of beams. Taking the beam weights, x, as the variable, one can mathematically define a
function aiming to achieve a desired dose distribution, d, and find the optimal solution
of this function. Such function is called the objective or cost function and the process to
search for the optimal solution of the objective function is called the optimization, both of
the above are crucial in the optimization process. The definition of a reasonable objective
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function sets the goal of the optimization. The desired dose distribution is used for the
physical-based optimization. The method used to search for the optimal solution affects the
time and efficiency of the treatment plan optimization. Ideally one wants a search method
being able to converge to the optimal solution in the shortest possible time. The details
of the objective function and the optimizing method used in this work is discussed in the
following two sections, respectively.
3.4 Objective Function Definition
The objective function is usually defined in the quadratic form as shown in Equation 3.3 for







(di − dpres)2 (3.3)
In the above generic equation, the difference between the dose deposited to the ith voxel,
di, and the prescribed dose, dpres, is squared to eliminate the negative value. The sum of all
the squared differences for all N voxels is divided by the number of voxels and finally results
into a single cost value. In order to achieve a uniform PTV dose coverage, one needs to find
the optimum set of beam weights, x, that results in a minimum cost value of the objective
function. As there is typically no set of beam weights that achieves all doses inside the
PTV equal to the dose prescription, the best solution is the one that minimizes the objective
function, f , so that the doses to all the voxels are similar or close to the prescribed dose.
It is clear that the only variable in Equation 3.3 is dose, so the dose-based objective
function is straightforward and easy to implement. However, this objective function needs
to be modified in order to improve its suitability for the clinical usage and to increase its
flexibility by taking the dose-volume objectives into account.
3.4.1 Dose-Volume Objectives
Typically, a clinician may want to deliver radiation doses so that “no more than X % of
the organ volume receives more than Y unit of the radiation dose”. In this situation the
dose-based objective function cannot satisfy the clinical goals sufficiently, because it does
not include the volume information. In order to relate the dose and volume information,
a plan evaluation tool, called the dose volume histogram (DVH), becomes necessary in the
optimization process.
The DVH is often used to show the dose-volume information of a treatment plan. The
cumulative DVH is frequently used [9]. The cumulative DVH is a graph to show the volume
percentage of a given organ receiving a specific dose. The DVH provides the planner with
the dose-volume information of a plan. For an ideal plan, in which the PTV receives 100
percent of the prescribed dose everywhere inside and no dose was delivered to the OAR, the
cumulative DVH for a PTV is the positive-half of a top-hat function, while the OAR DVH
has zero area under the curve as shown in Figure 3.2, curve 1 and 2, respectively. However,
in reality the dose is not strictly as conformal as desired, because the conformity of the PTV
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cannot be achieved without the compromise of the OAR sparing. The under-dosed (cold
spot) and the overdosed (hot spot) regions are reflected by the inward bending and outward
bending curvatures on curve 3 in Figure 3.2. If the OAR is located close to the PTV, there
will be doses delivered to the OAR as shown by curve 4 in Figure 3.2.
Figure 3.2: Ideal PTV and OAR DVH curves (1 & 2) and typical real PTV and OAR curves
(3 & 4).
Figure 3.3: Three points can be used in the dose-volume-based optimization to increase the
PTV dose uniformity and the OAR sparing.
The optimization with dose-volume objectives uses the DVH to relate the prescribed dose
and volume information, so that the dose-volume objectives can be specified [38, 39, 40]. In
the example shown in Figure 3.3, three basic dose-volume points are specified on the DVH,
two on the PTV curve and one on the OAR curve. Since the aim of the optimization is
to increase the steepness of the PTV DVH, thus improve the PTV dose uniformity, one
point is specified near the cold spot region also referred as the minimum DVH objective and
the other is specified in the hot spot region, referred to as maximum DVH objective. The
third point is specified below the OAR DVH. With this approach the dose delivered to the
OAR can be reduced. Together, the three dose-volume objectives allow the optimization to
improve the general quality of the treatment plan.
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Figure 3.4 illustrates using the DVH to apply the specified dose-volume objectives [38, 39].
In this example, the objective is defined as no more than Vpres% of the OAR should receive
dpres amount of radiation dose. Therefore, the aim of this example is to find beam segment
weights which result in the DVH passing through or below the objective point (dpres, Vpres).
Graphically, as long as a plan results in a DVH with the shadowed area in Figure 3.4 to be
zero, the plan satisfies the dose-volume objective.
In terms of implementation of the dose-volume objectives, during each iteration the
DVH needs to be calculated before the objective function is calculated. The algorithm then
searches on the current DVH to find the dose, dn, that is received by the objective volume,
Vpres. Any dose between dpres and dn is then penalized, so that the shadowed area shown in
Figure 3.4 reduces to zero. The beam weights are then re-adjusted in order to minimize the
objective function.
Figure 3.4: Illustration of the implementation of the dose-volume objective point in the
optimization.
One can modify the dose-based objective function shown in Equation 3.3 to implement
the dose-volume objectives. Since the only variable in the objective function is dose, the
Heaviside function is useful in the determination and calculation of the objective function
here. The Heaviside function is a step function shown in Equation 3.4 and it can be used to
specify the range of doses.
H(a− b) =
{
1, a− b ≥ 0
0, a− b < 0 (3.4)
Using the Heaviside function to specify the dose range, the dose-based objective function
in Equation 3.3 can be modified to apply the dose-volume objectives.
For a single PTV and a single OAR the dose-volume-based objective function may be
defined as following:







H(di − dcold)H(dpres − di)(di − dpres)2 (3.5)
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H(dn − di)H(di − d0)(di − d0)2 (3.7)
For this particular example the combined objective function is:
ftotal = ωPTV,cold · fPTV,cold + ωPTV,hot · fPTV,hot + ωOAR · fOAR (3.8)
In Equation 3.5 - 3.7, NPTV and NOAR are the number of voxels in the PTV and the
OAR, respectively. di is the dose deposited to the i
th voxel in the organs. dpres and d0 are
the doses specified by the PTV and the OAR dose-volume objectives. dcold, dhot and dn are
the doses received by the constrained volumes on the current DVH, they are found using the
method shown in Figure 3.4. Equation 3.8 sums all objective function results with different
weighting factors, ω, to calculate the total cost value.
The role of the Heaviside functions in the above equations is to specify a range of doses to
be taken into account based on the predefined dose-volume objectives. One example is shown
in Figure 3.4. On the other hand, the dose-based objective function shown in Equation 3.3
takes all the unsatisfied doses into account.
Comparing with the conventional dose-based objective function, only a certain range
of doses in the DVH contributes to the calculation of the objective function in the dose-
volume-based objective function. With the dose-volume specification capability the dose-
volume-based optimization is more flexible and suitable for clinical usage.
However, the advantage comes with a compromise. One drawback is that during every
objective function calculation, the DVH has to be calculated and the corresponding dose dn
(in Figure 3.4) has to be determined on the curve in order to specify the range of doses to
include in the calculation. This process of regenerating the 2D dose-volume information and
searching the dose range prolongs the optimization time regardless of the speedup resulting
from the reduction in the dose range. This effect becomes significant as the number of
objective function calculations increases due to a random starting point that is far away
from the optimal solution (details in Section 3.5).
3.4.2 Lambda Optimization Algorithm
From a mathematical point of view, one can realize that the conventional dose-based opti-
mization algorithm is a special case of the dose-volume-based optimization algorithm. Taking
the optimization of the OAR as an example, the conventional dose-based optimization pe-
nalizes the shadowed area as shown in graph in Figure 3.5, while the dose-volume-based
objective function uses the 2D information from the DVH to specify the range of doses and
penalizes the shadowed area shown in Figure 3.4. The specification of the dose range in
Figure 3.4 allows the dose-volume-based optimization to reach a clinical acceptable solution
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since less area on the DVH is penalized. It is worth noting that the optimal solution of the
dose-volume-based optimization and the one of the conventional dose-based optimization are
different due to the different definitions of the objective function.
Figure 3.5: The conventional dose-based optimization penalizes the full dose range on the
DVH. The dpres in this example is the prescribed tolerant dose to the OAR.
Figure 3.6: Illustration of the dose penalization using the lambda-value-dose-based objective
function. The algorithm penalizes (a) the doses greater than the prescribed dose in order
to reduce hot spot in an organ and (b) the doses less than the prescribed dose in order to
reduce the cold spot in an organ. λ is the ratio of dn − dpres to dmax − dpres in (a) and
dpres − dn to dpres − dmin in (b).
The dose-volume-based approach is computationally more expensive, as the dose-volume
information has to be calculated during each objective function calculation. The dose points
included the longer this calculation takes. In this work, a novel optimization algorithm mod-
ified from the conventional dose-based optimization, henceforth referred to as the lambda-
value-dose-based objective function, was developed in order to speed up the optimization
using the conventional dose-based objective function. Rather than using the volume and the
DVH to specify the dose range for objective function calculation, the dose range is calcu-
lated using a λ value, which is defined as the proportion of the unsatisfied dose range to be
considered in the objective calculation (see Figure 3.6).
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In the implementation the objective function terms are also classified as two types de-
pending on the side of the prescribed dose where the unsatisfied doses are calculated. The
formulae of the lambda-value-dose-based optimization are shown as follows.







H(di − dn)H(dpres − di)(di − dpres)2 (3.9)












ωleft,k · fleft,k +
Nright∑
k=1
ωright,k · fright,k (3.11)
In Equation 3.9 and 3.10, N is the total number of voxel in that particular organ, di is the
dose at the ith voxel, dpres is the prescribed dose for the PTV or the dose objective defined
by the treatment planner for the OAR. The value of dn is calculated using Equation 3.12
and 3.13 depending on the type of objective function.
dn calculation for fleft:
dn = (1− λ) · dpres + λ · dmin, where 0 < λ ≤ 1 (3.12)
dn calculation for fright:
dn = (1− λ) · dpres + λ · dmax, where 0 < λ ≤ 1 (3.13)
The λ value is a user defined value to specify the range of the dose to be calculated in
objective function. For different objectives the value of λ can be different depending on the
user emphasis. Nleft and Nright in Equation 3.11 are the number of objectives specified. The
values of ω are the relative weighting factors for the different objectives.
According to Figure 3.3 and 3.6, the objective function term for the PTV cold spot can
be replaced by fleft while PTV hot spot and the OAR calculation can use fright. The total
objective value can be calculated by multiplying each objective value with weighting factor,
ω and then adding up to a single cost value using Equation 3.11.
Equations 3.9 to 3.11 are similar to Equations 3.5 to 3.7 used in the dose-volume-based
optimization with the exception of the definition of the dose range. Instead of using the
DVH to find the value of dn received by Vpres% of organ (Figure 3.4), the modified algorithm
calculates the dose range using the λ value in only the dose dimension.
Because the treatment planner can specify the range of unsatisfied doses to be considered
in the optimization, the lambda-value-dose-based objective functions provide more degrees
of freedom to optimize the plan, comparing to the conventional dose-based objective func-
tion shown in Equation 3.3. When λ = 1, Equation 3.9 to 3.11 become the same as the
conventional dose-based objective function, Equation 3.3.
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Unlike the dose-volume-based objective function in Section 3.4.1, the lambda-value-dose-
based algorithm calculates the dose range in a one-dimensional space during each iteration
of the objective calculation. Therefore the computational process is more straightforward
and the calculation time is shortened.
However, the modified algorithm has one limitation. The simplification of dose range
calculation eliminates the volume information. Since the optimization is conducted in the
dose-coordinate only, the final objective value does not necessarily represent whether a cer-
tain dose is received by less than a certain volume. Thereby, it is not as clinically useful as
the dose-volume-based optimization algorithm.
Based on the above limitation, one may question the reason to “degenerate” the opti-
mization from the dose-volume-based back to the dose-based optimization in this work. The
answer is two fold, firstly the introduction of the λ value increases the relaxation and flexibil-
ity of the conventional dose-based optimization by reducing the dose range to be calculated;
secondly the usage of 1D calculation of the dose range improves the speed of the overall op-
timization comparing to the dose-volume-based optimization. Results of this improvements
will be shown in Chapter 5.
Figure 3.7: Illustration of the dose-volume-based and lambda-value-dose-based objective
function optimization. The difference lies on the calculation of the value dn to determine
the dose range in the objective function calculation.
The optimization process using the dose-volume-based and dose-based objective function
is shown in Figure 3.7. The optimization starts at a randomly generated starting point, x0,
and then using Equation 3.3 to calculate the point doses, d, received by the organ. Depending
on the choice of the objective function, the program either plots the DVH and finds the value
of dn for the dose-volume-based optimization or it calculates dn using Equation 3.12 or 3.13.
Finally, the Heaviside function is defined and the objective function can be calculated and
minimized. The process of looking for the value of dn is the critical difference that defines
the speed of the algorithm. Since the calculation of dn is only in a 1D space (dose-based
objective function) rather than in a 2D space (dose-volume-based objective function), the
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former algorithm should be faster than the latter one. The comparison between the two
optimization algorithms will be discussed in Chapter 5.
3.5 Optimal Solution Search Algorithm
As stated in Section 3.3, the two essential components of an optimization process are the def-
inition of objective function and the optimal solution search technique. The first component
has been discussed in Section 3.4; in this section the second component will be introduced.
For any given (convex or non-convex) function f(x), one can solve the function for all
possible x values to be guaranteed to find the minimum solution to f(x). The number
of possible combinations can be calculated using Equation 3.14 [48]. In this equation, the
number of combination, C, is given by a power relationship between m and k, where the
power k is the number of variables and the base m is the possible states of each variable.
For example, if x is a vector of three components and each component can have two states
(say spin-up or spin-down), x has 8 possible combinations of the variable components for
the calculation of f(x).
C = mk (3.14)
As the size of the vector variable and the possible states increases, the total number of
combinations increases following the power curve of Equation 3.14. The vector variable x
in the above example represents the beam segment weights vector, x, in Equation 3.1 and
the possible states represents the available weights. Obviously it becomes impractical to
exhaustively search the optimal solution by calculating the values of the objective function
for all possible beam weight combinations. For example, the number of beam segments used
in this work is around 200 and each one may have possible beam weight ranging from 0
to 50 in step of 0.1 MU, say. As a result the total number of combination is ˜9.3 × 10539.
Techniques to search the space of x in a more logical manner rather than the brutal force
method are required and have been studied previously.
Two of most significant and widely used search techniques in treatment plan optimization
are gradient-based techniques and simulated annealing [49]. The gradient-based algorithm
is classified as a deterministic algorithm. Taking a non-convex function with one variable
as an example, shown in Figure 3.8. If the problem is to find the value of x that minimizes
f(x). The gradient-based method searches along the descent gradient, so that the following
inequality is always true, where ∆s is the variable increment step size [50, 51, 52].
f(xk + ∆s) < f(xk) (3.15)
Figure 3.8 shows that the function reaches the global minimum at x = 7. If the search
begins at x = 5 or x = 8 and the increment step size is less than 2 or 1, respectively, the
search is definitely able to find the global minimum. However, if for instance the starting
point is at x = 17 and searches every one unit of x, then the gradient-based method will be
trapped at a local minimum at x = 14. In another case, if the starting point is at x = 2 and
the algorithm searches in steps of 2, the search will overlook the global minimum at x = 7
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and give the minimum at x = 6. As a result, in the gradient-based search both starting point
and increment step size are crucial to the result. Because it uses the gradient of the function
as the basis of the search, on the one hand for any arbitrary starting point if there exists
a local minimum between the starting point and the global minimum the gradient-based
algorithm might be trapped at the local minimum. On the other hand, if a bigger increment
step size is chosen there is a possibility to get out of the local minimum trap, but the bigger
step size may result in missing the global minimum.
Figure 3.8: A randomly generated one-variable, non-convex function with the global mini-
mum at x = 7.
Unlike the former technique, the simulated annealing is a stochastic algorithm that uses
a random search technique and certain transition probability to search for the optimal solu-
tion [50, 51, 52]. The random search allows the algorithm to explore more space than just
following the descent gradient from a predefined starting point. The transition probability
is a decay exponential form based on the Boltzmann’s distribution that enables the algo-
rithm to “generously” accept some unexpected solution (e.g. f(xk + ∆s) > f(xk)) during
the optimization. Therefore, with enough randomness the simulated annealing algorithm is
able to find the globally optimal solution with less chance to get stuck at a local minimum.
However, the compromise of the bigger probability to find the optimal solution is the pro-
longed optimization time due to the random searching, especially for a function with a large
variable set as in the case of IMAT. Furthermore, the selection of transition probability is
crucial since over acceptance may lead to longer optimization time while tight acceptance
may result in trapping at the local minimum.
3.6 Implementation in MATLAB
The standard Prism TPS does not have an optimization process designed for the 2-step
IMAT technique. Work on developing optimization program within the Prism TPS using
Common Lisp was conducted. The objective functions were programmed, but the process
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stopped at the development of the optimal solution searching algorithm code for its com-
plexity of programming in the low level language. Since the optimum search algorithm is
not the main aim of this work, to simplify the work and concentrate on the radiotherapy
development, MATLAB R© (MathWorksTM , Version 7.8.0.347(R2009a), USA) software was
chosen to perform the optimal solution search task because of its powerful optimization
toolbox package.
In MATLAB the optimization consists of two parts, the objective function script and the
optimal solution search algorithm script. In this work, both the dose-volume-based and the
lambda-value-dose-based objective functions were programmed into the MATLAB scripts for
the use of the treatment plan optimization. In the optimal solution search algorithm script,
certain type of optimal solution search algorithm is called upon the objective function to look
for the solution giving a minimum cost value. It contains the program to call the particular
algorithm to perform the optimal solution search on an objective function. There are both
gradient-based and simulated annealing algorithms pre-developed in the MATLAB software.
In this work, only the gradient-based algorithm was used for the time reasons.
The MATLAB build-in function used in this work was called “fmincon”, which uses the
so called quadratic programming (QP) method [50, 51, 53] to solve the QP problem that
have quadratic form of objective function. Since it is impossible to deliver a radiation beam
with negative intensity, the lower boundary constraint of beam weight vector, x, was set to
zero. As the gradient-based algorithm is used in this work, each iteration of the optimization
starts from random starting points within the space of the beam weight vector, x in order
to reduce the chance being trapped at a local minimum.
3.7 Prism and MATLAB Data Interaction
To this point, the two main programs developed in this work have been introduced in detail.
The entire treatment planning process is completed in two steps and in two separate program
environments. The original radiotherapy treatment plan is generated in the Prism TPS while
the treatment plan optimization process is conducted in MATLAB. This section discusses
the method to connect two systems so that the treatment plan data can be transferred
between two systems without confusion or unnecessary changes.
Refer back to Section 3.2, the dose points are first created inside the organs of interest.
Once the treatment plan was generated in Prism, the normalized matrix, M, is calculated.
Then this matrix is saved to the local drive for further use in MATLAB.
The point doses are calculated based on Equation 3.1 in MATLAB. The MATLAB scripts
will then optimize the point doses by altering the segment weights, x in Equation 3.1. Once
a satisfactory result or the best result the optimization can achieve has been found, the
optimization stops and saves the optimized segment weights to the local drive.
A Common Lisp code was developed to read the file containing all the optimized segment
weights and assign each weight to the corresponding beam segment in Prism. Up to this
stage, the entire treatment planning process is completed. Using the optimized segment
weights, the treatment planner can calculate and display the dose distribution in Prism.
The detailed flowchart of the entire process is shown in Figure 3.9.
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Figure 3.9: The flowchart to illustrate the working structure of the complete treatment plan
generation process in both Prism and MATLAB.
3.8 Concluding Remarks
In this chapter, the concept of the treatment plan optimization has been introduced. The
non-convolution dose calculation algorithm used in this work simplifies the dose calculation
to matrix multiplication shown in Equation 3.1. In this work, both the dose-based and dose-
volume-based optimizations were implemented and used to optimize the segment weights of
a treatment plan. For the dose-based optimization, a modified objective function that uses
the lambda value to specify the dose range was developed in order to increase the flexibility of
the dose-based optimization. The optimal solution search algorithm used in this work is the
gradient-based algorithm for its fast and simple application. The entire treatment planning
process was completed in two environments, Prism and MATLAB. Both the program codes
in Common Lisp and MATLAB were developed in order to transfer the data between the
two programs in simple steps. Note that the main programs have been developed, so that
the 2-step IMAT radiotherapy technique can be investigated. In the following chapter, an
analysis on the setup parameters is performed.
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Chapter 4
Analysis of Setup Parameters
Accurate dose calculation in the treatment planning system depends on the dose calcula-
tion algorithm and the size of the dose voxels. Large voxels speed up the calculation but
compromise the true dose representation and vice versa. The dose sampling affects the
accuracy and the speed of the dose calculation. The first analysis examines the choice of
dose voxel size that keeps the dose calculation efficient. Since 2-step IMAT is a rotational
treatment, a suitable number of beam angles is necessary to approximate a continuous irra-
diation. Therefore, the second analysis is to determine the number of angles sufficient for a
reasonable approximation. After choosing suitable number of angles, the two parameters of
the 2-step IMAT technique, i.e. the ratio of the two segments and the second segment width
at each gantry angle are altered, one at a time, to find a suitable setup. Finally, the number
of gantry rotations will be analyzed to find the effect of the gantry rotation on the quality
of the plan.
4.1 Phantom
All analysis in this chapter is based on a geometrical phantom. The phantom used is shown
in Figure 4.1. It is based on the horseshoe phantom used by Bratengeier [4] and has the same
dimensions. This particular phantom was chosen for its concave-shaped PTV that surrounds
the OAR. In such a situation it is challenging to plan a conformal dose coverage while sparing
the OAR using conventional 3D CRT. It should be noted that a similar arrangement of organs
commonly appears in clinical cases, such as head & neck, prostate and paraspinal tumors.
The geometric phantom consists of three organs, the PTV, the OAR and the external
contour. Similar to clinical CT image data, the geometric phantom is represented by a
collection of transverse slices, on which the organ contours are outlined. Practically, the
phantom contours were generated using an Excel spreadsheet and then transferred into the
Prism format. The Prism TPS has the ability to copy contours to other slices by clicking
buttons, but it is considered too labor intensive for a phantom with many slices. For example,
the user has to copy the contours 60 times for a 30cm long phantom with slices separated by
0.5cm. Therefore, some Common Lisp codes were developed to read the contour data from
the spreadsheet and automatically generate the entire phantom slices in the phantom file.
The code was specifically designed for generating Prism file of cylindrical organ contours.
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Figure 4.1: Transverse view of the geometric phantom (yellow: PTV, red: OAR, green:
external contour). (Regenerated based on Bratengeier’s paper [4]).
4.2 Grid Size Analysis
The dose sampling is crucial in the dose calculation during the treatment plan evaluation.
A uniform sampling method is used in this work for its simplicity (refer to Section 3.2).
The accuracy and the speed of the dose calculation depends on the selection of the voxel
size. A small voxel size provides more accurate dose calculations, but the compromise is
the prolonged time consumption and large computational cost. Ultimately, one wants to
sample as many points as necessary to achieve a high accuracy within a reasonable time
frame. Therefore, the aim of this first analysis was to determine a reasonable voxel size for
dose sampling to achieve sufficient accuracy in the dose calculations.
A 2-step IMAT treatment plan was generated with the following constant parameters:
the angle step size was 5◦, the ratio of the 1st beam segment to the 2nd beam segment for
each gantry direction was fixed to 1.5. The width of the 2nd segment was fixed to 1.5cm. The
choice of the above parameters was based on the previous investigation reported elsewhere
[54] (abstract in Appendix A).
The analysis is divided into two parts in order to find a reasonable voxel sizes for the PTV
and OAR separately. The dose points with different voxels sizes are generated in a given
organ. Prism calculates the corresponding normalized matrices, M shown in Equation 3.1.
The matrices are then transferred into MATLAB for further calculation. Assuming the dose
calculation of the smallest voxel size represents the most accurate dose result, since the finest
voxel size contains the most dose points which provides more dose-volume information. The
matrix of the finest voxel size is used to calculate the point doses inside that particular organ
using Equation 3.1. A MATLAB code was developed to automatically adjust the segment
weights vector, x, so that the DVH is normalized to D95 point. The D95 is the dose that is
received by 95% of the organ volume. In other words, on the DVH diagram the above point
is located at the coordinate (100, 95%). Using the finest voxel size matrix, the DVH was
calculated. The segment weights vector, that normalized the DVH to D95, is then used to
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calculate the DVHs of other voxel sizes.
Based on the assumption made previously, the DVH function V (d) calculated from the
finest voxel size is used as the reference. For all other larger voxel sizes the root mean square




(V (di)− Vref (di))2 (4.1)
The summation range is from i = 0 to the maximum dose on the DVH plot, dmax. In
this work all DVH is plotted up to 120cGy, so dmax = 120 for the increment step size of
1cGy. V (di) and Vref (di) are the percentage volumes, that receive di dose, based on the
dose calculation of certain voxel size and the finest voxel size, respectively. This RMS is the
measure of the total percentage volume difference between the DVH calculated based on the
finest voxel size and a certain larger voxel size. Therefore, the summation is not divided by
the total number of dose index to give the average difference. It was expected that the RMS
difference increases with voxel size.
The minimum voxel size for the PTV without running out of the computer memory was
0.3cm, so the 0.3cm DVH was the reference for the RMS difference calculation. The voxel
size increases to 1cm in 0.1cm steps. For voxel sizes larger than 1cm, large increments values
of the voxel size were selected up to 2.5cm in order to investigate the trend.
The finest voxel size for the OAR was 0.2cm, so the 0.2cm DVH was the reference for
the RMS difference calculation. The voxel size increases to 0.5cm in 0.1cm steps. For voxel
sizes greater than 0.5cm, arbitrary voxel sizes were chosen.
The related PTV values for different voxel sizes from 0.3cm to 2.5cm are shown in
Table 4.1. A similar work was conducted to find the suitable voxel size for the OAR.
Table 4.2 shows the results for voxel size from 0.2cm to 2.0cm.
The time of dose calculation is consistent with the number of points inside the PTV as
the voxel size decreases. The plots of the two graphs are shown in Figure 4.2. The curve
suggests that as the voxel size increases beyond 1.5cm, it will not materially improve the
simulation time.
Figure 4.3 shows that the dose calculation speed increases as well as the RMS differ-
ence (Equation 4.1) as the voxel size increases. A voxel size of 0.7cm was decided to be a
compromise between calculation speed and accuracy as shown in Figure 4.3.
Figure 4.4 shows the consistent drop in both number of dose points and the calculation
time for the OAR. Figure 4.6 shows the trends of the calculation time and the RMS as the
voxel size changes. The voxel size of 0.4cm was chosen for a good compromise between speed
and accuracy. The choice is mainly based on the OAR DVH comparison shown in Figure 4.5.
Assuming the 0.2cm voxel size provides the most accurate representation of the OAR DVH,
the 0.4cm voxel size is the closest approximation with a shorter dose calculation time (the
voxel size of 0.3cm for the OAR run out of memory when calculate the PTV and the OAR
at the same time).
The accuracy of the dose calculation is an important process in the treatment planning,
but so is the speed of the calculation. Based on this analysis it was decided that a suitable
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Voxel Sizes (cm) Number of Points Calculation Time RMS
0.3 48444 NA NA
0.4 20750 22.09min 0.06
0.5 10560 11.31min 0.07
0.6 6239 6.73min 0.08
0.7 3738 3.98min 0.11
0.8 2436 2.57min 0.13
0.9 1804 1.99min 0.15
1.0 1320 1.41min 0.14
1.3 640 41.89s 0.17
1.5 406 26.62s 0.21
1.8 246 16.86s 0.29
2.0 170 10.68s 0.39
2.5 80 5.56s 0.62
Table 4.1: Results for the PTV with voxel sizes between 0.3cm and 2.5cm. The calculation
time of 0.3cm voxel size is missing because the computation run out of memory.
Voxel Sizes (cm) Number of Points Calculation Time RMS
0.2 35800 39.82min NA
0.3 10428 11.21min 0.16
0.4 4425 4.91min 0.32
0.5 2240 2.52min 0.49
0.8 516 32.24s 0.52
1.0 320 21.26s 1.17
1.5 84 5.43s 1.96
2.0 45 3.03s 2.43
Table 4.2: Results of the OAR with voxel sizes between 0.2cm and 2.0cm.
Figure 4.2: The number of points inside the PTV and the dose calculation time versus voxel
sizes from 0.4cm to 2.5cm.
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Figure 4.3: The dose calculation time and the RMS difference versus PTV voxel size.
Figure 4.4: The number of points inside the OAR and the normalized matrix calculation
time versus voxel size.
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Figure 4.5: OAR DVHs plotted using the voxel sizes from 0.2cm to 0.5cm. Although about
5cGy difference of the maximum OAR dose between the 0.2cm and 0.4cm DVHs, the 0.4cm
is the smallest OAR voxel size that does not run out of memory during the calculation
involving both the PTV and the OAR.
Figure 4.6: The normalized matrix calculation time and the RMS versus OAR voxel size.
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voxel size for the PTV was 0.7cm and for the OAR was 0.4cm.
It was noted that for similar number of dose points, the RMS of the OAR was always
larger than the one of the PTV. Take the PTV voxel sizes of 0.5cm and OAR voxel size
of 0.3cm for example, the number of points inside the PTV was only 1.25% more than the
number of points inside the OAR, but the RMS difference of the PTV is 56.3% better than
the one of the OAR. One can also observe from Figure 4.7 that the slope of the OAR RMS
curve is greater than the one of the PTV RMS. This may be explained by that there is a
steep dose gradient in the OAR, so the accuracy of the DVH depends more on the voxel size
in the OAR case than in the PTV case.
Figure 4.7: Comparison between the RMS difference of the PTV and the OAR.
4.3 Angle Step Size Analysis
2-step IMAT treatment is a rotational technique during which the target is irradiated con-
tinuously while the gantry rotates around the patient. Ideally an infinite number of beams
is required to simulate such treatment, but it is not practical to do so. Therefore, only a
finite number of beams is used during treatment planning to approximate the continuous
treatment. In this analysis, the trade-off of using a finite number of beams in the TPS
is investigated. The radiation is delivered every certain degrees and the angle separation
between two adjacent beams is called the angle step size.
The number of beams used depends on the angle step size, i.e. the smaller the step
size the higher the number of beams and the better the approximation. However, a large
number of beams not only prolongs the time for the dose calculation, but also complicates
the treatment plan optimization as the dimension of the optimization variable is defined by
the number of beams (see Equation 3.1). The aim of this analysis is to find the appropriate
angle step size for the 2-step IMAT treatment simulation, which gives a reasonable accuracy
with as little calculation time as possible.
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From the previous analysis, the voxel sizes of the PTV and the OAR were chosen to be
0.7cm and 0.4cm, respectively, so that the doses can be calculated efficiently. The width of
the second segment at each angle was fixed to 1.5cm and the ratio of two beams at each
angle was kept at 1.5.
Treatment plans with different angle step sizes were generated in the Prism TPS, and the
normalized matrix M was used to calculate the DVH of the PTV and the OAR in MATLAB.
All the DVH plots were normalized to D95 = 100cGy. The number of beams and the time
for the dose calculations were compared with the homogeneity index (HI) of the PTV. The
HI is defined as the ratio of the maximum dose in the PTV to the PTV prescribed dose or










HIdiff = HImax −HImin (4.4)
For a perfectly conformal dose distribution, one expects the value of HI to be one, as
the maximum and minimum doses correspond to the prescribed dose. In this work, the
difference between the maximum and minimum HI was also used (see Equation 4.4) as an
indication of the general homogeneity of the plan. The ideal value for HIdiff is zero, which
corresponds to a uniform PTV coverage.
Since the simulation run out of memory for the 1◦ angle separation, the 2-step IMAT
treatment plans were generated with the angle step size varied between 2◦ and 15◦. The
results of each run are listed in Table 4.3.
Angle Step Size(◦) 2 3 4 5 10 15
Number of Beam Segments 612 412 304 244 124 84
Calculation Time (min) 21.74 14.64 10.81 8.69 4.43 3.07
HImax 1.1160 1.1179 1.1162 1.1191 1.1366 1.2402
HImin 0.9890 0.9896 0.9880 0.9886 0.9862 0.9719
HIdiff 0.1271 0.1283 0.1281 0.1305 0.1504 0.2682
Table 4.3: Results of the angle step analysis.
The number of beams decreases as the angle step size increases, the time for the dose
calculations follows a similar pattern as shown in Figure 4.8. Such result is expected as the
more the number of beams the longer the dose matrix calculation time, since the column
number of the matrix M in Equation 3.1 represents the number of beams.
Figure 4.9 shows the plot of the HImax and the HImin versus angle step size. As the angle
step size decreases, the values of the HImax and the HImin approach unity which implies that
the treatment plan becomes more homogeneous. This is due to the increased number of
beams that conforms a better dose distribution for smaller angle step size. The difference
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Figure 4.8: Dose calculation time and the number of beams decreases as the angle step size
increases.
between the HImax and the HImin, HIdiff , is plotted in Figure 4.10. The curve suggests that
the 5◦ angle step size may be a suitable choice for approximating the rotational treatment,
since the value of the HIdiff does not improve significantly. The above can also be concluded
from Figure 4.11, which is a plot of the calculation time versus HIdiff . Figure 4.11 illustrates
that as the angle step size increases, the calculation time drops due to less number of beams,
while the value of the HIdiff increases. The first four vertically distribution points represent
the results of angle step size from 2◦ to 5◦ (refer to Table 4.3). The ideal solution of the
curve is the one that gives minimum values for both axes but such solution does not exist
in this case. The 5◦ angle step size was chosen, because the HIdiff only improves by 1.8%
while the calculation time increases by 19.6% from 5◦ to 4◦.
Figure 4.9: The homogeneity indices approach unity as the angle step size decreases.
Figure 4.12 shows the comparison between DVH of the 2◦ and 5◦ angle step size plan,
40
Figure 4.10: The homogeneity index difference approaches to approximately zero as the
angle step size decreases.
Figure 4.11: Graph of dose calculation time versus homogeneity index difference. The ho-
mogeneity index difference does not improve much as the angle step size smaller than 5◦.
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while Figure 4.13 shows the comparison between the DVH of the 5◦, 10◦ and 15◦ angle
step size plan. Assuming the 2◦ plan is the best approximation of a rotational treatment.
Since the 2◦ and 5◦ plans are consistent with each other, this indicates that 5◦ is a good
approximation of a rotational treatment. Considering in the number of beams, the 5◦ plan
consists of only no more than 40% of the beam numbers of the 2◦ plan. As a result, the
5◦ plan requires less time to calculate the doses and optimize the beam weights for this
reduction in the variable dimensions.
Figure 4.12: DVH comparison between 2◦ and 5◦. (100% dose =100cGy)
Figure 4.13: DVH comparison between 5◦, 10◦ and 15◦.
Using the homogeneity index and DVH, the angle step size was chosen to henceforth be
5◦ to approximate the rotational treatment during the simulation.
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4.4 Segment Weight Ratio Analysis
One characteristic of the 2-step IMAT technique is its discrete approximation of the non-
uniform beam intensity, see Figure 1.6. The ratio of the 2nd order segment weight to the 1st





The aim of this analysis is to find the effect of varying the fixed segment ratio on the
resultant plan quality. The segment weight ratio that gives the best plan quality for the
phantom will be used as a constant for later analysis. In Chapter 5, the segment weight will
be optimized to increase the quality of the treatment plan.
The 2-step IMAT plans were simulated using a 5◦ angle step size and the second order
beam segment width was set to 1.5cm at each angle. The dose points were sampled every
0.7cm in the PTV and 0.4cm in the OAR.
A MATLAB program was developed to calculate the doses and related parameters for
segment weight ratio, in range of 0.1 to 2 in steps of 0.1. The MU of the beam segments
were adjusted while keeping a constant ratio, so that the DVH of the PTV was normalized
to D95 = 100cGy.
The related parameters of this analysis are listed in Table 4.4.
Segment Weight Ratio MUTotal Dmean HImax HImin HIdiff
0.1 460.72 131.4 1.5208 0.8936 0.6272
0.2 476.02 127.3 1.4625 0.9025 0.5601
0.3 489.82 123.6 1.4102 0.9105 0.4997
0.4 502.31 120.3 1.3629 0.9178 0.4452
0.5 513.64 117.3 1.3200 0.9244 0.3956
0.6 525.40 114.8 1.2841 0.9329 0.3513
0.7 536.77 112.6 1.2524 0.9417 0.3108
0.8 548.39 110.8 1.2255 0.9517 0.2738
0.9 560.65 109.5 1.2035 0.9635 0.2399
1.0 572.28 108.2 1.1830 0.9748 0.2082
1.1 585.31 107.4 1.1679 0.9890 0.1790
1.2 597.54 106.6 1.1533 0.9892 0.1641
1.3 609.91 106.0 1.1408 0.9888 0.1520
1.4 621.91 105.4 1.1293 0.9887 0.1406
1.5 633.85 104.9 1.1191 0.9886 0.1305
1.6 645.34 104.5 1.1095 0.9857 0.1237
1.7 658.31 104.4 1.1188 0.9804 0.1383
1.8 670.05 104.2 1.1320 0.9738 0.1582
1.9 682.30 104.1 1.1463 0.9685 0.1778
2.0 693.72 104.0 1.1594 0.9628 0.1966
Table 4.4: Results of the segment weights ratio analysis.
As the segment weight ratio increases, the total number of MUs required increases lin-
early, as shown in Figure 4.14, while the mean dose of the PTV on the other hand decreases
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as shown in Figure 4.15. A high mean dose indicates a poor dose uniformity as the plans
were normalized to D95 = 100cGy. One wants to generate a plan with less number of MU
while remaining the PTV mean dose at a low level. Based on the previous two graphs, it is
not straightforward to select the segment weight ratio to use.
Figure 4.14: Linear relationship between the total MU and the segment weight ratio.
Figure 4.15: Decrease of the PTV mean dose as the segment weight ratio increases.
Figure 4.16 shows the curves of HImax and HImin versus the segment weight ratio. The
curves indicate that a very low or high segment weight ratio degrades the plan quality. For
HImin, a ratio in the range between 1.1 and 1.5 is constantly close to the value one. While
the value of the HImax achieves a minimum at 1.6 segment weight ratio. The difference
between HImax and HImin is plotted in Figure 4.17. The smaller the value of HIdiff the more
homogeneous is the plan, since all plans were normalized to the same point on the DVH.
Figure 4.17 suggests that by setting the segment weight ratio to 1.6, the plan becomes the
most homogeneous.
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Figure 4.16: Changes in the HImax and HImin as the beam segment ratio increases.
Figure 4.17: The difference of HImax and HImin as a function of beam segment ratio.
4.5 Second Segment Width Analysis
The 2-step IMAT technique uses two beam segments to approximate the effect of the physical
filter. Since the width of the first order segment is fixed to cover the PTV, the width of
the second order beam segment can be a parameter to change to achieve a plan with better
quality. The aim of this analysis is to find the effect of the width of the second order segment
on the quality of treatment plan for the phantom.
The segment weight ratio of the beams at each angle was set to 1.6 from the previous
analysis and the beam angles were separated by 5◦. Dose points were uniformly sampled
using voxel size of 0.7cm in the PTV and 0.4cm in the OAR.
The gap between the PTV and the OAR was 1.0cm for the phantom. The second beam
segment width was varied from 1.0cm to 2.0cm. The plans were normalized to D95 = 100cGy
45
on the DVH as before. The MUTotal, HI, Dmean of the PTV and Dmax of the OAR were
recorded and compared.
Table 4.5 shows the results of the second beam width analysis. From this table it can
be seen that solutions in the range 1.4cm to 1.7cm give best results. As a result, four extra
widths (1.0cm, 1.3cm, 1.8cm and 2.0cm) were used to show the general trend.
2nd Segment Width (cm) MUTotal Dmean DOAR,max HImax HImin HIdiff
1.0 763.01 111.5 40.6 1.2208 0.9916 0.2291
1.3 679.44 106.5 37.6 1.1477 0.9906 0.1571
1.4 661.68 105.4 36.9 1.1280 0.9898 0.1382
1.5 645.34 104.5 36.3 1.1095 0.9857 0.1237
1.6 632.78 104.2 35.8 1.1158 0.9768 0.1390
1.7 620.89 104.0 35.4 1.1293 0.9684 0.1610
1.8 609.15 103.8 34.9 1.1410 0.9582 0.1828
2.0 590.16 106.6 34.9 1.1191 0.9311 0.2680
Table 4.5: Results of the second order beam segment width analysis.
Figure 4.18 shows the plot of the total MUs versus 2nd beam segment widths. The dose
delivery becomes more efficient as the 2nd beam width increases. The mean dose in the PTV
trend is shown in Figure 4.19, this general decreasing pattern is consistent with Figure 4.20
with the exception of the high mean dose for 2.0cm beam width. The cause of this increase
of mean dose is due to the increasing underdose area in the PTV near the OAR. Figure 4.20
shows the graph of the maximum OAR dose versus the width of the 2nd beam at each angle,
its declining curve is consistent with the total MU curve in Figure 4.18. This consistency
may relate to the setup of the beam portal of each segment. Since the MLC leaves are
always pushed to the edge of the OAR regardless to the beam width, as the MU decreases
the scattering contribution reduces and this is the reason of the gradually decrease in the
OAR maximum dose.
Figure 4.18: Decreasing trend of the total MU as the second segment width increases.
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Figure 4.19: Mean PTV dose versus the second segment width.
Figure 4.20: OAR mean dose decreases as the second segment width increases.
Figure 4.21 shows the comparison of the HI values. When normalized to D95 = 100cGy on
the DVH, the HImin slowly decreases as the 2
nd segment width increases. On the other hand,
the value of the HImax achieves the minimum at 1.5cm in Figure 4.21. The homogeneity
difference, HIdiff suggests that by setting the 2
nd segment width to 1.5cm the plan can be
the most homogeneous in the absence of segment weight optimization.
Using the total MU, mean and maximum doses, the results of the 2nd segment width
ranging from 1.3cm to 1.8cm are consistent with each other and as the 2nd segment width
increases, the quality of the plan becomes better with regards to dosimetry. On the other
hand, the results from the HI comparison suggests that the plan only can achieve its maxi-
mum homogeneity when the 2nd segment width is set to 1.5cm. One may use either methods
to determine the suitable choice of the 2nd segment width based on different aims, either
reducing the dose to the patient or increasing the homogeneity in the PTV.
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Figure 4.21: Effects of the change in second segment width on the homogeneity indices.
Figure 4.22 shows the DVH comparison of the 1.5cm and 1.8cm 2nd segment width plans
as an illustration of the homogeneity advantage of the 1.5cm plan.
Figure 4.22: DVH comparison between the 1.5cm and 1.8cm 2nd segment width plans. (100%
dose =100cGy)
The 2nd beam width was chosen to be 1.5cm for its higher homogeneity in the PTV. Such
setup will be used in the next analysis to compare the effects of the number of rotations of
the 2-step IMAT technique.
4.6 Rotation Number Analysis
As shown in Figure 2.5, there are two regions of the PTV not overlapping with the OAR,
hence they are both suitable for 2-step IMAT irradiation. However, due to the physical
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limitations of the MLC leaves, only one region can be irradiated at one time without rotating
the MLC leaves. One can deliver radiation to both regions in two rotations with each rotation
irradiating one side, or one may only irradiate one region in a single rotation to reduce the
treatment time. In the case of 2-step IMAT, there are two segments for each irradiation
region, so there will be four rotations required to deliver the ideal intensity profile shown in
Figure 2.6.
The aim of this analysis is to find if there is any improvement in the quality of the
treatment plan by doubling the number of rotations. In this work, the plan that delivers
the “ideal” intensity profile as shown in Figure 2.6 is called “double side” (4-rotations) as it
delivers the radiation to both PTV regions. The plan that delivers half intensity profile as
shown in Figure 2.7 is called “single side” (2-rotations).
In this analysis, two 2-step IMAT treatment plans were generated with the same param-
eters selected in the previous sections. The voxel size of the PTV was 0.7cm and the voxel
size of the OAR was 0.4cm for the dose calculation. The beam angles were sampled every
5◦. The beam segment ratio at each angle was fixed to 1.6 and the width of the second beam
segment was set to 1.5cm.
The only difference between the two treatment plans was that the “single side” plan
only irradiates the PTV on one side of the OAR from every gantry angle, while the “double
side” plan irradiates both regions of the PTV that do not overlap with the OAR. The beam
segments are illustrated in Figure 4.23. The “single side” plan only requires two rotations to
deliver the first and second order beam segments of the 2-step IMAT treatment, while the
“double side” plan requires four rotations.
Figure 4.23: The “single side” plan (a) only irradiates one side of the PTV, while the “double
side” plan (b) irradiates both sides of the PTV. For a 2-step IMAT, each segment requires
one gantry rotation to deliver.
The normalized results are shown in Table 4.6.
It shows in the Table 4.6 that the dose calculation time of the “double side” plan is about
twice of the one of the “single side” plan, since the number of beams is doubled. This may
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Single Side Double Side Change (%)
Number of Beams 112 244 NA
Calculation Time (min) 4.47 8.69 +48.6
MUTotal 667.42 645.34 -3.3
HImax 1.1921 1.1095 -6.9
HImin 0.9128 0.9857 +7.4
HIdiff 0.2793 0.1237 -55.7
DPTV,mean 108.0 104.5 -3.3
DOAR,max 49.0 36.3 -26.0
DOAR,mean 23.0 22.3 -3.3
Table 4.6: Results of the rotation number analysis.
be the most convincing argument for the speed advantage of the “single side” treatment
plan. However, the rest of parameters all show the improvement by irradiating both regions
of the PTV.
The total MU of the “double side” plan was 3.3% less than the one of the “single side”
plan. Both HImax and HImin approach unity by around 7% after irradiating the other part of
the PTV. The most significant of all is that the value of the HIdiff dropped by 55.7%, which
indicates that the “double side” plan is more homogeneous than the “single side” plan. Such
improvement in the homogeneity can be observed from the DVH of the two plans shown in
Figure 4.24.
Figure 4.24: PTV and OAR DVH comparison of the “single side” and “double side” treat-
ment plans. (100% dose =100cGy)
Dosimetrically, the “double side” plan is able to reduce the mean dose to the PTV and
the OAR by about 3% and the maximum dose delivered to the OAR was reduced by 26%.
These three parameters indicate that a more conformal does distribution can be achieved
using the “double side” plan and the OAR can also be more spared.
The dose distribution shown in Figure 4.25 are the results from this analysis for “single
side” and “double side” plans, respectively. The asymmetrical dose distribution in the “single
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side” plan shown in Figure 4.25a results from delivering one side of the intensity bank as
shown in Figure 2.7. Previous literature also indicated a similar asymmetrical pattern shown
in the transversal plane, see Figure 4.26 [4].
Figure 4.25: Dose distribution of the “single side” plan (a) and the “double side” plan (b).
The improved symmetry can be observed. (red: 107cGy, green: 100cGy, blue: 95cGy, white:
90cGy, purple: 75cGy, yellow: 50cGy, cyan: 30)
Figure 4.26: The dose distribution of a 2-step IMAT treatment plan from Bratengeier’s paper
[4]. The asymmetrical distribution of 70% to 80% isodose lines can be observed.
4.7 Concluding Remarks
In this chapter, the study on the 2-step IMAT was conducted in a geometric phantom based
on the Bratengeier’s previous literature [4]. The first analysis was to investigate the suitable
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dose voxel size for dose sampling inside the phantom, because the voxel size affects the time
and the efficiency of the dose calculation. Based on the analysis of the particular phantom
used in this work, the voxel sizes of 0.7cm and 0.4cm were chosen for the PTV and the
OAR, respectively. Since the irradiation is continuously delivered to the phantom during
the gantry rotation but it is impractical to sample the beam in an infinitely small angle step
size, an analysis was conducted to find a reasonable angle step size approximation which
produce as few beam segments as possible while maintain the quality of the rotational plan.
In a 2-step IMAT plan, there can be two parameters to adjust to improve the quality of
the plan, the segment ratio between 1st and 2nd order segments and the width of the 2nd
order segment at each angle. The analysis in this chapter found that the segment ratio
of 1.6 and 2nd order segment width of 1.5cm provides the best plan quality. Finally, an
analysis investigating the effect of the gantry rotation number on the quality of the plan
was conducted. As the treatment delivers the ideal PTV coverage shown in Figure 2.6, the
treatment time was doubled, but the homogeneity of the PTV dosage improved by more
than 50% and the OAR was spared 26% more. In the next chapter, the treatment plan that
is generated with the parameter setups found in this chapter will be optimized in term of




The 2-step IMAT treatment plans generated in Chapter 4 had the segment weight ratio
fixed. Such plans resulted in a high dose region at the edge of the PTV and some inner
parts of the PTV as well (see Figures 4.24 and 4.25). Hot spots inside and outside the PTV
reduce the general quality of the treatment plan. Therefore, treatment plan optimization
is required to reduce this high dose and increase the uniformity of the PTV. In this work,
both the dose-based and the dose-volume based objective functions were used to optimize
the segment weights in order to further improve the quality of the plan.
5.1 Aim
The aim of this analysis was first to improve the plan quality of 2-step IMAT plans by
optimizing the segment weight, i.e. MUs, of each beam using both the dose-based and
the dose-volume-based objective functions. Secondly, the two optimization processes were
compared in terms of time and achieved plan quality.
5.2 Method
The 2-step treatment plan with 1.5cm second beam segment width and 5◦ angle step size was
generated in Prism. The plan was a “double side” plan, in which the gantry fully rotated
around the phantom four times each time delivered one segment at an angle. The plan
was then optimized using the dose-based and the dose-volume-based objective functions in
MATLAB.
The parameters of the dose-volume-based objective functions are listed in Table 5.1, this
optimization uses the objective functions shown in Equation 3.5, 3.6 and 3.7.
ωPTV ωOAR dcold Vcold dhot Vhot dn Vn
0.8 0.2 99.5 98% 102 70% 25 20%
Table 5.1: Dose-volume-based objective parameters setup. Name of parameters refers to
Equations 3.5-3.7.
The parameters of the dose-based objective functions are listed in Table 5.2, this opti-
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mization uses the modified dose-based objective functions, Equation 3.9, 3.10 and 3.11 in
Section 3.4.2. For λ = 1, the optimization becomes the conventional dose-based objective
function, which is shown in Equation 3.3, that considers the full range of the unsatisfied
doses. On the other hand, the objective function terms only consider a partial range of the
unsatisfied doses for λ = 0.5.
ωPTV ωOAR λPTV /λOAR
0.8 0.2 0.5 or 1
Table 5.2: The lambda-value-dose-based objective function parameter setup, the value of λ
is set to 1 or 0.5.
5.3 Results and Discussion
The results are listed in Table 5.3. The non-optimized plan was compared with three dif-
ferent optimized plans, using the dose-volume-based objective function and the dose-based
objective function algorithms, respectively. The last two columns are the results of the dose-
based objective function, which uses the lambda-value-dose-based objective functions that
uses the λ value to specify the dose range for the optimization.
Non-Opt DV Opt D Opt (λ=1) D Opt (λ=0.5)
Opt Time (min) NA 11.9 2.3 1.8
Obj Value NA 0.84 2.48 1.48
MUTotal 645.34 683.70 605.23 612.47
HImax 1.1095 1.0480 1.0480 1.0545
HImin 0.9857 0.9830 0.9860 0.9830
HIdiff 0.1237 0.0650 0.0620 0.0715
DPTV,mean 104.5 101.8 102.3 102.2
DOAR,max 36.3 44.7 33.1 36.4
Table 5.3: Results of the non-optimized plan (Non-Opt) and the plans optimized using
dose-volume-based optimization (DV Opt) and dose-based optimization (D Opt).
As shown in Table 5.3, after optimization the quality of the treatment plan has generally
improved in different aspects for different objective functions. The values of the HIdiff are
about halved after the optimization, in other words, the dose distribution inside the PTV
becomes more conformal after the optimization. Such effect can be observed in Figure 5.1,
which shows the DVH of the non-optimized plan and the plan optimized using dose-based
objective function with λ = 1 as an example. The improved homogeneity reduces the PTV
volumes that receive high doses. The total MU after the dose-based objective function is
reduced by about 6% and a general dose reduction in the OAR (see Figure 5.1). Because the
beam segments of all treatment plans are the same and the MLC leaves on the OAR side
shadow the OAR completely, less MU leads to less radiation leakage into the OAR through
the MLC leaves. Such relationship between the MU and the maximum OAR dose can also
be observed by comparing the DVH of the non-optimized plan with the plan optimized
using the dose-volume-based optimization shown in Figure 5.2. Values from Table 5.3 shows
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that the total MU in fact has increased by 31.9% after the dose-volume-based optimization,
and this results a 18.8% increase in the OAR maximum dose in Figure 5.2. In general, the
optimization is able to improve the PTV dose uniformity, the following analysis will compare
the plan qualities of different objective functions.
Figure 5.1: DVH comparison between non-optimized plan and the plan optimized using
dose-based objective function. (λ = 1) (100% dose =100cGy)
Figure 5.2: DVH comparison between non-optimized plan and the plan optimized using
dose-volume-based objective function. (100% dose =100cGy)
The time taken to optimize the treatment plan is significantly different for the dose-
volume-based and dose-based objective functions. Starting at the same starting point, the
dose-volume-based objective function takes about six times longer to optimize the treatment
plan than the dose-based optimization. This shows the speed advantage of the dose-based
objective function. Additionally, the results of the dose-based objective function that in-
cludes the entire range of the unsatisfied doses (when λ = 1) are generally superior than
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the dose-volume-based objective function results (see Table 5.3). Although using the dose-
volume-based objective function is results 0.5% less mean dose in the PTV , the dose-based
objective function is able to conform the dose distribution with 4.6% higher homogeneity.
Figure 5.3: MU distribution of the plan optimized using the dose-volume-based objective
function.
Figure 5.4: MU distribution of the plan optimized using the dose-based objective function.
(λ = 1)
The total MU required by the plan optimized using the dose-based objective function
was 11.5% less than the one optimized using the dose-volume-based objective function. As a
result, the maximum dose inside the OAR was reduced by 30.0%. Figure 5.3 and 5.4 show the
MU distribution of all the segments after dose-volume-based and dose-based optimization,
respectively. The total number of the beam segments for both plans was 244. The gantry
starts from 0◦ and rotates clockwise in a step size of 5◦. At each angle, the number of beam
segments is either four (two on each side of the PTV) or two (in situation when one side
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Figure 5.5: MU difference of the dose-volume-based and dose-based optimization.
of the PTV overlaps with the OAR). The two highest peak distributions of the MU values
at the range between 80 and 100 and the range between 150 and 170 in Figure 5.3 and 5.4
represent the high MU of beams at gantry angle around 140◦ and 220◦, respectively.
Figure 5.5 shows the difference between the MU distribution of the dose-volume-based
and dose-based optimization. The reduction of the MU values at two peak regions and the
increased MU values at other angles spreads the radiation more evenly around the phantom
using the dose-based optimization. This results less radiation deposited into the lower part
of the normal tissue, as shown in Figure 5.6, 5.7 and 5.8, which are the dose distribution after
the dose-volume-based and dose-based optimization. Figure 5.9 shows the DVH comparison
between these two plans and the slightly better OAR sparing due to the less total MU can
be observed.
Figure 5.6: Dose distribution of the dose-volume-based optimized plan. (red: 107cGy, green:
100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan: 30)
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Figure 5.7: Dose distribution of the dose-based optimized plan (λ = 0.5). (red: 107cGy,
green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan: 30)
Figure 5.8: Dose distribution of the dose-based optimized plan (λ = 1). (red: 107cGy, green:
100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan: 30)
The dose-based optimization is faster than the dose-volume-based optimization, this para-
graph will compare the dose-based optimization that uses λ = 1 and λ = 0.5. By taking
the full range of the unsatisfied doses, the quality of the plan can be improved more than
only taking partial range of unsatisfied doses. The dose distribution shown in Figure 5.7
and 5.8 show the reduced doses to the normal tissue by setting λ to 0.5 and 1, respectively.
Figure 5.10 is the DVH comparison of two λ settings and it visually presents the improved
OAR sparing by setting λ = 1.
In general, both the dose-based and the dose-volume-based optimization algorithms are
able to improve the quality of the treatment plan by increasing the steepness of the PTV
DVH. Such improvement in the dose conformity of the PTV may compromise the sparing of
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Figure 5.9: DVH comparison between dose-volume-based optimized plan and the plan opti-
mized using dose-based optimization. (λ = 0.5) (100% dose =100cGy)
Figure 5.10: DVH comparison between the plans optimized using dose-based optimization.
(λ = 0.5 and λ = 1) (100% dose =100cGy)
the OAR to some extent, but as long as the maximum OAR dose is within the tolerance dose
the plan may still be acceptable. This increased maximum dose inside the OAR after the
optimization may be the result of the lower value of the OAR weighting factor, ωOAR, during
the objective calculation. In the above analysis, the weighting factor of the OAR is set only
one quarter of the weighting factor of the PTV, since the main goal of the optimization is to
improve the homogeneity of the PTV dose distribution. As a result, the optimization may
tolerate the unsatisfied doses in the OAR more than the PTV in turn lead to the increased
maximum OAR dose. One solution may be to increase the weighting of the OAR so that the
calculation of the OAR objective will contribute more in the optimization. Table 5.4 shows
the results of the dose-based optimizations that use λ = 0.5 and two different settings of the
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D Optλ=0.5 ωPTV = 0.8,ωOAR = 0.2 ωPTV = 0.7,ωOAR = 0.3
Opt Time (min) 1.8 2.0







Table 5.4: Results of plans optimized using dose-based optimization (λ = 0.5) with different
weighting factor setups.
weighting factors. As the value of the OAR weighting factor increases, the OAR becomes
more important in the objective calculation. As a result, the maximum OAR dose is reduced
by 3.8% which is 1.3 dose units less than the non-optimized plan. Such reduction is also
linked to the smaller total MU of the newly optimized plan. Figure 5.11 shows the DVH
comparison between the two ratio setups and Figure 5.12 shows the dose distribution of the
plan by increasing the OAR weighting in the optimization.
Figure 5.11: DVH comparison between the plans optimized using dose-based optimization
(λ = 0.5) with different weighting factor settings. (100% dose =100cGy)
5.4 Concluding Remarks
In summary, the optimization is able to improve the uniformity of the PTV and reduces the
dose to the OAR thus increases the quality of the plan. Comparing between dose-based and
the dose-volume-based objective functions, the former algorithm is generally faster because it
calculates the dose range (either full or partial range) one-dimensionally instead of doing so in
a 2D space during every objective function calculation of the optimization. Furthermore, the
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Figure 5.12: Dose distribution of the dose-based optimized plan (λ = 0.5, ωPTV = 0.7 and
ωOAR = 0.3). (red: 107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy,
yellow: 50cGy, cyan: 30)
time required to optimize the plan is in the order of minutes. Such short time of optimization
may be the result of a “fortunate” starting point and a “not-so-bad” local minimum. The
lambda-value-dose-based objective functions developed in this work has the functionality to
allow the planner to choose the range of unsatisfied doses to be considered in the objective
function calculation. Such functionality makes the optimization more flexible, because the
modified algorithm is able to relax the objective function calculation in situation when it is




In the previous chapters the segment generation and segment weight optimization have been
addressed. For simplicity, the implementation of the above was tested on a semi-realistic
geometrical phantom. In this chapter, the full implementation of 2-step IMAT was applied
to a clinical case. Therefore, the aim of this part of work is to test the Prism and MATLAB
codes on a clinical case and compare the 2-step IMAT plans with the conventional arc therapy
plan.
6.1 Method
The clinical case used in this chapter is a paraspinal tumor case from the University of
Wu¨rzburg. The original organs-of-interest include the PTV (concave shaped) and OARs
(the spinal cord and both lungs). Due to the current implementation of the beam portal
shaping program, only one PTV and one OAR can be taken into account. Therefore, the
organs-of-interest in this work are the PTV and the spinal cord, as shown in Figure 6.1.
Figure 6.1: The transverse view of the PTV (cyan contour) and the spinal cord (green
contour).
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A conventional arc therapy treatment plan, which only delivers the first order beam
segments shown in Figure 4.23b to cover the PTV at each angle, was created along with two
types of the 2-step IMAT treatment plans, namely, two rotations (shown in Figure 4.23a)
and four rotations (shown in Figure 4.23b). The beam angles were sampled every 5◦ and the
dose points were sampled every 0.2cm and 0.1cm in the PTV and the OAR, respectively. The
second segment width for the 2-step IMAT plan was 1.2cm, which was chosen empirically so
that the second segment was able to cover the gap between the PTV and the OAR as well
as some inner part of the PTV.
The normalized matrix, M in Equation 3.1 was calculated in Prism and then transferred
to MATLAB for optimization purpose. The segment weights were optimized using the dose-
volume-based objective function as well as the lambda-value-dose-based objective function
with the parameter values listed in Table 6.1 and 6.2. After the optimization, all plans were
normalized to D95 = 100cGy on the DVH.
ωPTV ωOAR dcold Vcold dhot Vhot dn Vn
0.8 0.2 99.5 98% 107 10% 45 5%
Table 6.1: Dose-volume-based objective function parameters setup. Name of parameters
refers to Equations 3.5-3.7.
ωPTV ωOAR λPTV /λOAR
0.8 0.2 0.5 or 1
Table 6.2: The lambda-value-dose-based objective function parameter setup, the value of λ
is set to 1 or 0.5.
6.2 Results and Discussion
The results of the conventional arc therapy after optimization are listed in Table 6.3. The
results of the 2-rotation 2-step IMAT treatment plan after the optimization are shown in
Table 6.4. The results of the 4-rotation 2-step IMAT treatment plan after the optimization
are shown in Table 6.5.
Conv. Arc DV Opt D Opt λ=1 D Opt λ=0.5
Opt Time (s) 79.95 44.54 13.36
MUTotal 301.0 292.2 293.0
HImax 1.1816 1.1540 1.1688
HImin 0.9056 0.8913 0.8964
HIdiff 0.2760 0.2627 0.2724
DPTV,mean 107.0 107.5 107.5
DOAR,max 52.9 48.2 48.7
Table 6.3: Conventional arc therapy after the dose-volume-based optimization and dose-
based optimizations.
Figures 6.2, 6.3 and 6.4 show the comparison of the DVH of different plans optimized by
each objective function.
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2 rotations DV Opt D Opt λ=1 D Opt λ=0.5
Opt Time (s) 130.09 39.96 30.88
MUTotal 347.6 350.4 345.1
HImax 1.1082 1.1054 1.1113
HImin 0.9531 0.9121 0.9176
HIdiff 0.1551 0.1933 0.1937
DPTV,mean 102.6 102.8 102.7
DOAR,max 53.8 44.4 46.2
Table 6.4: 2-rotation 2-step IMAT treatment plan after the dose-volume-based and dose-
based optimizations.
4 rotations DV Opt D Opt λ=1 D Opt λ=0.5
Opt Time (s) 452.49 109.21 73.92
MUTotal 325.5 333.7 325.2
HImax 1.0698 1.0736 1.0705
HImin 0.9366 0.9107 0.9125
HIdiff 0.1332 0.1629 0.1580
DPTV,mean 102.0 102.3 102.2
DOAR,max 49.3 42.2 43.8
Table 6.5: 4-rotation 2-step IMAT treatment plan after the dose-volume-based and dose-
based optimizations.
Figure 6.2: DVH comparison between the conventional arc therapy, 2-rotation and 4-rotation
2-step IMAT plans optimized by dose-volume-based objective function.
With the results shown in Tables 6.3, 6.4 and 6.5, the quality of the plan using different
techniques were compared. The improvements in the maximum and minimum homogeneity
indices and the decreases in the homogeneity indices difference indicated that the advantage
of using the 2-step IMAT technique in unifying the PTV doses. For example, after the dose-
volume-based optimization the homogeneity indices difference of the 2-step IMAT plans were
about 40% and 50% lower than the one of the conventional arc therapy plan. The above
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Figure 6.3: DVH comparison between the conventional arc therapy, 2-rotation and 4-rotation
2-step IMAT plans optimized by lambda-value-dose-based objective function. (λ=0.5)
Figure 6.4: DVH comparison between the conventional arc therapy, 2-rotation and 4-rotation
2-step IMAT plans optimized by lambda-value-dose-based objective function. (λ=1)
improvements can also be observed from the DVH shown in Figures 6.2, 6.3 and 6.4 suggested
consistently that the “extra” beam segment of the 2-step IMAT technique indeed improved
the PTV dose uniformity. After the same optimization, the conventional arc therapy cannot
achieve a PTV dose coverage as uniform as the 2-step IMAT plans. At the same time, the
2-step IMAT is able to spare the OAR slightly better than the conventional arc therapy.
It is worth to mention here that the number of beam segments of the conventional arc
therapy and the 2-rotation 2-step IMAT plans were similar, both slightly over 100 segments
(the former plan creates one segment for each side of the PTV in Figure 4.23b and the
latter one creates two segments for one side of the PTV only in Figure 4.23a). Although
the number of segments are similar, the 2-rotation 2-step IMAT was able to deliver a better
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conformed plan due to the feature of the intensity modulation. As a proof-of-principle, this
result agrees with the previous literatures of Bratengeier [4] and it shows the improvement
of the plan quality by intensity modulation.
On the other hand, the conventional arc therapy requires less MUs to deliver, which
implies that less MLC leakage dose during the treatment. However, due to the inhomogeneity
of the conventional arc therapy, the mean dose of the conventional arc therapy plan is about
5cGy more than the mean dose of the 2-step IMAT plans. Depending on the optimization,
the maximum OAR dose difference between the conventional arc therapy and the 2-step
IMAT plans varies, but a general dose reduction in the OAR can be observed form the DVH
shown in Figures 6.2, 6.3 and 6.4.
After the optimization, the beam segment weights were import back to Prism in order to
determine the dose distribution of each plan. Figures 6.5 - 6.13 show the dose distributions
of the transverse, coronal and sagittal planes for three types of the treatments after the
dose-volume-based optimization.
Figure 6.5: Dose distribution of the conventional arc therapy in the transverse plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
In the transverse plane (Figures 6.5, 6.6 and 6.7), the conventional arc therapy was able to
conform around the PTV but also resulted a “hot spot” around the PTV and nearby normal
tissues. Conversely, the 2-step IMAT plans reduced the size of the “hot spot” within the
PTV in order to achieve a uniform dose coverage. However, the optimization resulted high
dose region in one side of lung. This compromise is mainly because of two reasons, the beam
portal shaping program and the computer equipments limitation. The current beam portal
shaping program in this work was only designed for one PTV and one OAR, none of lungs
were avoided by beam segments, so the radiation to the lungs cannot be physically reduced
using the MLC. Furthermore, due to the limitation of the current computer resource, the
computation runs out of memory for too many dose points calculation in Prism. Therefore
neither side of lung was taken into consideration during the optimization, since the dose
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Figure 6.6: Dose distribution of the 2-rotation 2-step IMAT in the transverse plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
Figure 6.7: Dose distribution of the 4-rotation 2-step IMAT in the transverse plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
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Figure 6.8: Dose distribution of the conventional arc therapy in the coronal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
Figure 6.9: Dose distribution of the 2-rotation 2-step IMAT in the coronal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
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Figure 6.10: Dose distribution of the 4-rotation 2-step IMAT in the coronal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
Figure 6.11: Dose distribution of the conventional arc therapy in the sagittal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
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Figure 6.12: Dose distribution of the 2-rotation 2-step IMAT in the sagittal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
Figure 6.13: Dose distribution of the 4-rotation 2-step IMAT in the sagittal plane. (red:
107cGy, green: 100cGy, blue: 95cGy, white: 90cGy, purple: 75cGy, yellow: 50cGy, cyan:
30)
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points matrix, M, for lungs has to be calculated first in Prism. In future work, both problems
will be solved in order to improve the functionality of the 2-step IMAT implementation.
The “hot spot” region was also reduced in both the coronal and sagittal planes by using
the 2-step IMAT technique (as shown in Figures 6.8, 6.9, 6.10, 6.11, 6.12 and 6.13). Such
results agree with the DVH calculated in MATLAB and shows the advantage of the 2-step
IMAT technique over the conventional arc therapy.
Comparing the two types of 2-step IMAT plans, the homogeneity indices difference of
the 4-rotation plan was more than 10% better than the one of the 2-rotation plan. For
the same optimization, the maximum OAR dose was decreased by about 5% to 8%. The
improvements can also be observed on the DVH comparison in Figures 6.2, 6.3 and 6.4. The
improvements can also be observed in the dose distribution, for example, the hot spot in the
transverse plan was significantly reduced in the 4-rotation 2-step IMAT plan (see Figures 6.6
and 6.7).
With regards to the optimization time, the dose-volume-based optimization takes longer
than the dose-based optimization, regardless to the type of treatment plan (refer to Tables 6.3
- 6.5). Furthermore, the relaxation in the dose-based optimization by reducing the value of
lambda from 1 (considering the entire dose range) to 0.5 (considering partial dose range),
the optimization time can be shortened while keep the quality of the plan similar.
6.3 Concluding Remarks
In summary, the work shown in this chapter demonstrated that the PTV dose uniformity
advantage of the 2-step IMAT technique over the conventional arc therapy technique. This
agrees with the results from the previous literature [4]. Furthermore, the implementation
indicated that the 2-step IMAT program developed in this work has the potential to be
applied to clinical cases. However, there are aspects of the program need to be improved in
order for it to work for general cases. One urgently required improvement is to include more
than one OAR in the treatment plan optimization. By increasing the computer memory and




7.1 Discussion and Future Work
In this work, the 2-step IMAT technique was implemented into the Prism TPS and a GUI was
developed to allow the generation of 2-step IMAT plans in an automatic manner. The beam
segments were created using a modified ray-tracing technique, which is able to generate
beam segment shapes that avoid the OAR. This technique uses only the organ contours
information, therefore the error due to spatial resolution of the point matrix that is created
on the organ contour projection in the BEV (refer to Figure 2.3) can be eliminated. As a
result, regardless of the size of the organ, any organ is “visible” in the BEV as long as there
are contours plotted for the organ. However, the current implementation of the beam portal
shaping technique has its limitation. It is only designed for cases consisting of one PTV and
one OAR. It is an active area of future work to expand the current program code, so that
the more organs can be considered during the beam portal shaping.
The dose grid size analysis suggested that a point grid size of 0.7cm and 0.4cm was
accurate choice for the PTV and the OAR of the phantom, respectively, while conserving
the calculation time and equipment resources. In this work, Common Lisp codes were
developed to include the ability to calculate doses in different organs using different grid
sizes. Such functionality is essential in order to provide equally accurate dose results for
different size organs, especially when the size of the organ as well as the dose gradient is
different. The angle step size analysis showed that in order to approximate the rotation
treatment efficiently, the beam angle can be sampled every 5◦.
The 2-step IMAT technique uses two beam segments to approximate the ideal beam
intensity profile as generated by a physical filter in Brahme’s original work. As a result,
during the treatment planning process there are two possible parameters that can be altered,
the ratio of the two beam segments and the width of the second order segment. The setups
of the above parameters that result in the best plan quality were 1.6 and 1.5cm, respectively,
for the phantom used. The analysis was conducted by changing one parameter at a time,
this is not practical clinically and the result may only apply to the particular phantom used
in this work. Additionally, the width of the second segment at each angle was set to be
constant for simplicity. In fact, the width may vary based on the organ and gantry angle
geometries, so that the quality of the plan can be maximized. Finally, the relationship of
parameter setups for circle shaped PTV and OAR was illustrated in Bratengeier’s previous
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paper [25, 26], in future it is worth to implement such relationship into Prism.
Recall from the example shown in Section 2.2.3 and the analysis study in Section 4.6, in
the case of one OAR surrounded by one PTV, at any given angle there are at most two PTV
regions that do not overlap with the OAR. Due to the physical limitations of the MLC leaves,
it is not always possible to deliver radiation to both regions at the same time. Therefore,
only one region can be irradiated at each gantry angle during one rotation. The question
comes to whether it is necessary to double the rotation numbers to deliver the ideal plan
or it is sufficient enough to spend half of the time to irradiate only part of the PTV region
at each angle. An analysis was performed in this work to compare the two possible plans
with regards to time and dosimetry. The results of the phantom study suggested that by
doubling the treatment time (i.e. the number of rotations) the homogeneity of the PTV dose
coverage may be improved by more than 50% and the OAR can be spared 26% more (refer
to Table 4.6).
The optimization process was conducted in MATLAB because of its build-in optimization
toolbox. The dose-based objective function has a quadratic form, a so called lambda-value-
dose-based objective function was developed in this work in order to increase the flexibility of
the generic dose-based objective function. By letting lambda equal to one the optimization
includes the entire dose range into the objective function calculation, while only partial dose
range is included for the value of lambda less than one. The segment weights of treatment
plans were optimized using the dose-based optimization as well as the dose-volume-based
optimization. The time consumption of the dose-volume-based optimization was 5 to 6 times
longer than the dose-based optimization in the phantom study. The reason is mainly due
to the usage of the 2D dose-volume information (i.e. DVH) to search for the dose range for
the objective function calculation in the dose-volume-based optimization. The introduction
of the lambda value in the lambda-value-dose-based objective function is able to search the
dose range in only 1D (dose domain), so the speed of the optimization becomes faster.
It is worth mentioning that due to this dimension reduction, the lambda-value-dose-based
optimization does not provide an absolute volume objective. As a result, the optimization
may continue although the plan has met the predefined dose-volume objective during the
optimization.
Unfortunately, none of the optimization resulted in an objective function of zero. This
means no solution is the real optimal solution in this work. From the treatment planning
point of view, this may be caused by the poor choice of the dose-volume objectives in the
dose-volume-based optimization. There are also two other explanations to it. Firstly, such
result may be due to the physical restriction of the radiation delivery, since negative MU
is impossible to achieve. This hard constraint of the optimization makes all components of
the variable x in Equation 3.1 positive numbers, such reduction in the acceptable variable
space filters out all the negative values of x in turn reduces the chance to find the solution
that gives null result of the objective function. Secondly, the optimum search algorithm
used in this work is the gradient-descend algorithm, which looking for solutions based on the
objective function slope. As discussed in Section 3.5, the choice of the starting point affects
the result of the search significantly. If there is local minimum along the descend gradient
between the starting point and the global minimum, the gradient search will be trapped
at the local minimum. Therefore, the none-zero result of the objective calculation may
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also indicate that the optimization is trapped at a local minimum. Both of the above two
reasons can cause the positive value of the objective calculation, the former one is impossible
to change at the moment since the negative radiation is not physically possible. However, the
possibility of trapping at a local minimum due to the gradient-descent search algorithm can
be reduced by two means, random starting points and stochastic algorithm. In this work,
the optimization iterated for many times and each time started from a randomly generated
starting point. This method aims to reduce the possibility of getting trapped at local minima
by exploring a larger solution space. The second way to avoid trapping at local minimum
is to use a stochastic algorithm, such as simulated annealing algorithm, to search for the
optimal solution. The simulated annealing was not used in this work, but its potential of
avoiding the local minimum encourages that it is worth to be implemented in future work.
The second beam segment width was fixed as a constant for all gantry angles in this
work, but this width can in fact be a function of gantry angle. By optimizing the width
of the second segment with regards to the organ geometry, the quality of the plan may be
improved. This required further study in determining the effect of the second segment width
on the quality of the plan.
Finally, the 2-step IMAT treatment plans were generated on a clinical case comparing
with the conventional arc therapy. After the segment weight optimization, the DVH was
plotted for each plan. Regardless to the type of objective function used, the 2-step IMAT
plans were more uniform than the conventional arc therapy in the PTV coverage while the
OAR was generally spared better at the same time. The 2-step IMAT plans were able to
improve the homogeneity of the PTV doses by about 40% to 50%. The dose distributions
on the transverse plane showed that 2-step IMAT was able to significantly reduce the “hot
spot” around the PTV. However, in the 2-step IMAT plans some parts of the lung received
a high doses after the optimization. This is mainly because the current beam portal shaping
program only works for two organs in total and the optimization did not take the lung into
consideration. Once the above two problems are addressed by implementing multiple organs
in both the segment generation process and the optimization and by increasing computer
memory, the 2-step IMAT implementation will be able to deliver treatment plans with even
better quality.
7.2 Conclusion
The 2-step IMAT that was introduced by Bratengeier has been implemented for the first
time into the Prism TPS. The beam portal shaping process was developed as an automatic
process. The treatment plan optimization programs using dose-based and dose-volume-based
objective function were developed in MATLAB to improve the quality of the treatment plan.
In this work, the dose-based optimization was performed using the so-called lambda-value-
dose-based objective function in order to increase the flexibility of the optimization. The
implementation of the 2-step IMAT technique into the clinical case indicated that the 2-step
IMAT is feasible. The comparison between the conventional arc therapy and 2-step IMAT
in the clinical case analysis demonstrated the advantage of the 2-step IMAT in the PTV
dose uniformity and OAR sparing. There are future work, such as considering more than
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two organs during the beam portal shaping process and optimizing segment weights using
the simulated annealing algorithm, to improve the 2-step IMAT implementation in order
to make it suitable for general clinical cases. In conclusion, the results from this work has
shown that 2-step IMAT is a viable technique. The two-beam-segments approximation of
the complex intensity profile allows 2-step IMAT to produce a uniform dose coverage while
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Introduction: Intensity-modulated Arc Therapy (IMAT) allows creating highly con-
formal treatment plans, which are supposedly superior to conventional intensity-modulated
radiation therapy in terms of treatment time and dose conformity [1]. However, planning
is complex and the relative benefits are not yet fully understood [2]. In this work we de-
scribe the implementation of a simplified technique called 2-step IMAT, which requires two
rotations of the gantry [3]. The beam segments for the first rotation are in analogy with
a conformal arc, i.e. with one aperture for each gantry angle reflecting the shape of the
target volume. The beam segments for the second rotation are narrow segments close to
the organ-at-risk (OAR) in order to achieve steep dose gradients on the edge of the tumour
adjacent to OARs.
Methods & Materials: 2-step IMAT was implemented into the University of Wash-
ington treatment planning system Prism using the Common Lisp Programming language.
The segments are automatically generated using 3D-anatomy information and ray-tracing.
An elliptical phantom was created with a concave planning target volume (PTV) and an
OAR. The width of the narrow segments as well as its relative weight was varied in order
to optimize the plan for the phantom. A comparison was carried out between a 4-field
3D-conformal plan, conformal arc plan and 2-step IMAT.
Results/Discussion: The 2-step IMAT plan showed the potential of significantly spar-
ing the OAR with regards to the other techniques (see Figure 1). However, the target dose
uniformity was not within the -5%/+7% criteria. The slight dose non-uniformity in the tar-
get was not unexpected since no beam weight adjustments had been made for the different
pathlengths from different gantry angles.
Conclusion: In this proof-of-principle study we have for the first time automated and
implemented the process of segment generation for 2-step IMAT and initial results indi-
cated that with this technique it is possible to create highly conformal treatment plans with
high dose gradients. To overcome the current limitations implementation of dose-volume
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constraint based optimization and further investigations on the effects of beam aperture
settings are required.
Figure 1: DVH for 3D conformal (triangle), single arc (diamond) and 2-step IMAT (square)
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